 AGREEMENT      * * *

 

  

  

  

AGREEMENT AND PLAN OF MERGER

  


 

  

dated as of May 4, 2010

  


 

  

by and among

  


 

  

SENORX, INC.,

  


 

  

C. R. BARD, INC.

  


 

  

and

  


 

  

RAPTOR ACQUISITION CORP.

  


 

  


 

  

 

  


  * * *

 

 

  

  

 

 

 

  

   

  

 

 

 

  

  

 

 

TABLE OF CONTENTS

  


 

  

Page

  

 

  

 

    

ARTICLE 1

  |  

THE MERGER

  |  

2

   
---|---|--- 
   |  

1.01

  |  

The Merger

  |  

2

   
   |  

1.02

  |  

Effective Time

  |  

2

   
   |  

1.03

  |  

Effects of the Merger

  |  

2

   
   |  

1.04

  |  

Certificate of Incorporation and Bylaws of the Surviving Corporation

  |  

3

   
   |  

1.05

  |  

Directors and Officers

  |  

3

   
   |  

1.06

  |  

Closing

  |  

3

   
   |  |  |   
  

ARTICLE 2

  |  

EFFECT OF THE MERGER ON THE CAPITAL STOCK OF THE COMPANY AND MERGER SUB

  |  

3

   
   |  

2.01

  |  

Effect on Shares of Capital Stock

  |  

3

   
   |  

2.02

  |  

Equity Awards

  |  

5

   
   |  

2.03

  |  

Payment for Common Shares in the Merger

  |  

8

   
   |  |  |   
  

ARTICLE 3

  |  

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  |  

10

   
   |  

3.01

  |  

Organization and Qualification

  |  

11

   
   |  

3.02

  |  

Charter Documents and Bylaws

  |  

12

   
   |  

3.03

  |  

Capitalization

  |  

12

   
   |  

3.04

  |  

Authority Relative to this Agreement

  |  

13

   
   |  

3.05

  |  

Company Subsidiaries

  |  

13

   
   |  

3.06

  |  

No Violation; Required Filings and Consents

  |  

13

   
   |  

3.07

  |  

SEC Reports; Financial Statements; Internal Controls

  |  

15

   
   |  

3.08

  |  

Compliance with Applicable Laws

  |  

17

   
   |  

3.09

  |  

Absence of Certain Changes or Events

  |  

17

   
   |  

3.10

  |  

Litigation

  |  

17

   
   |  

3.11

  |  

Information in Proxy Statement and Other Disclosure Documents

  |  

18

   
   |  

3.12

  |  

Benefit Plans

  |  

18

   
   |  

3.13

  |  

Taxes

  |  

21

   
   |  

3.14

  |  

Intellectual Property

  |  

22

   
   |  

3.15

  |  

Licenses and Permits

  |  

25

   
   |  

3.16

  |  

Material Contracts

  |  

25

   
   |  

3.17

  |  

Environmental Laws

  |  

28

   
   |  

3.18

  |  

State Takeover Statutes

  |  

29

   
   |  

3.19

  |  

Opinion of Financial Advisor

  |  

29

   
   |  

3.20

  |  

Brokers

  |  

29

   
   |  

3.21

  |  

Related Party Transactions

  |  

29

   
   |  

3.22

  |  

Properties and Assets

  |  

29

   
   |  

3.23

  |  

Labor Matters

  |  

30

   
   |  

3.24

  |  

Regulatory Matters

  |  

31

   
   |  

3.25

  |  

Insurance

  |  

34

   
   |  

3.26

  |  

Foreign Corrupt Practices

  |  

34

   
   |  

3.27

  |  

Export Controls

  |  

34

   
   |  

3.28

  |  

Sales Tracings

  |  

35

   
  

  

  

 

 

 

  

 

i  

  

 

 

 

  

  

 

TABLE OF CONTENTS

  

(continued)

  

Page

  

 

     

ARTICLE 4

  |  

REPRESENTATIONS AND WARRANTIES OF MERGER SUB AND PARENT

  |  

35

   
---|---|--- 
   |  

4.01

  |  

Organization and Qualification

  |  

35

   
   |  

4.02

  |  

Charter Documents and Bylaws

  |  

35

   
   |  

4.03

  |  

Authority Relative to this Agreement

  |  

36

   
   |  

4.04

  |  

No Violation; Required Filings and Consents

  |  

36

   
   |  

4.05

  |  

Financial Capability

  |  

37

   
   |  

4.06

  |  

Brokers

  |  

37

   
   |  

4.07

  |  

Litigation

  |  

37

   
   |  

4.08

  |  

Information in Proxy Statement

  |  

37

   
   |  

4.09

  |  

Ownership of Common Shares

  |  

38

   
   |  |  |   
  

ARTICLE 5

  |  

COVENANTS

  |  

38

   
   |  

5.01

  |  

Interim Operations.

  |  

38

   
   |  

5.02

  |  

Stockholders Meeting; Preparation of Proxy Statement

  |  

42

   
   |  

5.03

  |  

Filings and Consents

  |  

44

   
   |  

5.04

  |  

Access to Information

  |  

45

   
   |  

5.05

  |  

Public Announcements

  |  

46

   
   |  

5.06

  |  

Indemnification; Directors' and Officers' Insurance

  |  

46

   
   |  

5.07

  |  

Further Assurances; Commercially Reasonable Efforts

  |  

49

   
   |  

5.08

  |  

Third Party Standstill Agreements

  |  

49

   
   |  

5.09

  |  

No Solicitation

  |  

49

   
   |  

5.10

  |  

Termination of Registration

  |  

52

   
   |  

5.11

  |  

Employment Matters

  |  

53

   
   |  

5.12

  |  

Merger Sub

  |  

54

   
   |  

5.13

  |  

Stockholder Litigation

  |  

54

   
   |  

5.14

  |  

Section 16 Matters

  |  

54

   
   |  

5.15

  |  

State Takeover Statutes

  |  

54

   
   |  

5.16

  |  

Notification of Certain Matters

  |  

55

   
   |  

5.17

  |  

Retention Agreements

  |  

55

   
   |  

5.18

  |  

Corrective Action Plan

  |  

56

   
   |  |  |   
  

ARTICLE 6

  |  

CONDITIONS TO CONSUMMATION OF THE MERGER

  |  

56

   
   |  

6.01

  |  

Conditions to the Obligations of Each Party

  |  

56

   
   |  

6.02

  |  

Conditions to Obligations of Merger Sub and Parent

  |  

56

   
   |  

6.03

  |  

Conditions to Obligation of the Company

  |  

57

   
   |  |  |   
  

  

  

 

 

 

  

 

ii  

  

 

 

 

  

  

 

TABLE OF CONTENTS

  

(continued)

  

Page

  

 

     

ARTICLE 7

  |  

TERMINATION

  |  

58

   
---|---|--- 
   |  

7.01

  |  

Termination by Mutual Consent

  |  

58

   
   |  

7.02

  |  

Termination by Parent or the Company

  |  

58

   
   |  

7.03

  |  

Termination by Parent

  |  

59

   
   |  

7.04

  |  

Termination by the Company

  |  

60

   
   |  

7.05

  |  

Effect of Termination

  |  

60

   
   |  |  |   
  

ARTICLE 8

  |  

MISCELLANEOUS

  |  

60

   
   |  

8.01

  |  

Payment of Fees and Expenses

  |  

60

   
   |  

8.02

  |  

No Survival

  |  

63

   
   |  

8.03

  |  

Modification or Amendment

  |  

63

   
   |  

8.04

  |  

Entire Agreement; Assignment

  |  

63

   
   |  

8.05

  |  

Severability

  |  

64

   
   |  

8.06

  |  

Notices

  |  

64

   
   |  

8.07

  |  

Governing Law

  |  

65

   
   |  

8.08

  |  

Interpretation

  |  

65

   
   |  

8.09

  |  

Counterparts

  |  

66

   
   |  

8.10

  |  

Certain Definitions

  |  

66

   
   |  

8.11

  |  

Specific Performance

  |  

67

   
   |  

8.12

  |  

Extension; Waiver

  |  

68

   
   |  

8.13

  |  

Third Party Beneficiaries

  |  

68

   
   |  

8.14

  |  

Submission to Jurisdiction

  |  

68

   
 

   
 

  

 

  

 

 

 

  

 

iii  

  

 

 

 

  

  

 

TABLE OF CONTENTS

  

(continued)

  


 

  

Page

  

EXHIBIT A - VOTING AND SUPPORT AGREEMENT

 

  


 

  


 

  


 

   
 

 

 

 

  

 

iv  

  

 

 

 

   
 

AGREEMENT AND PLAN OF MERGER

  

  

THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of May 4, 2010,
is entered into by and among SENORX, INC., a Delaware corporation (the
"Company"), C. R. BARD, INC., a New Jersey corporation ("Parent") and RAPTOR
ACQUISITION CORP., a Delaware corporation indirectly wholly-owned by Parent
("Merger Sub").

  

  

RECITALS

  

  

WHEREAS, the board of directors of the Company (the "Company Board") has
unanimously (i) determined that this Agreement and the transactions
contemplated by this Agreement (the "Transactions") are advisable, fair to and
in the best interests of the Company and its stockholders, (ii) adopted
resolutions approving and declaring the advisability of this Agreement and the
Transactions, (iii) subject to the terms and conditions set forth herein,
resolved to recommend approval and adoption of this Agreement by the
stockholders of the Company and (iv) received a written opinion of the
Financial Advisor (as defined in Section 3.19) as set forth in Section 3.19
herein;

  

  

WHEREAS, the board of directors of each of Parent and Merger Sub has
unanimously (i) declared the advisability of this Agreement and (ii) approved
this Agreement and the Transactions;

  

  

WHEREAS, a wholly-owned subsidiary of Parent has adopted this Agreement in its
capacity as the sole stockholder of Merger Sub;

  

  

WHEREAS, the Company Board and the board of directors of Merger Sub have
approved the merger of Merger Sub with and into the Company, with the Company
as the surviving corporation, upon the terms and subject to the conditions set
forth in this Agreement and the Delaware General Corporation Law (the "DGCL"),
whereby (i) each issued and outstanding share of the common stock, par value
$0.001 per share of the Company (other than Common Shares to be canceled
pursuant to Section 2.01(b) and Dissenting Shares (as defined in Section
2.01(d))) (the "Common Shares"), shall be converted into the right to receive
the Merger Consideration (as defined in Section 2.01(a)), (ii) each Option (as
defined in Section 2.02(a)(i)) shall be converted into the right to receive
the Option Consideration (as defined in Section 2.02(a)(ii)), (iii) each share
of Restricted Stock (as defined in Section 2.02(b)) shall be converted into
the right to receive the Restricted Stock Consideration (as defined in Section
2.02(b)); (iv) each Restricted Stock Unit (as defined in Section 2.02(c))
shall be converted into the right to receive the RSU Consideration (as defined
in Section 2.02(c)) and (v) each Warrant (as defined in Section 2.02(d)(i))
shall be converted into the right to receive the Warrant Consideration (as
defined in Section 2.02(d)(ii));

  

   
 

 

 

 

  

   

  

 

 

 

   
 

WHEREAS, as a condition and inducement to Parent's and Merger Sub's
willingness to enter into this Agreement, simultaneously with the execution of
this Agreement, certain officers and stockholders of the Company listed on
Schedule I hereto and their respective affiliates are entering into a voting
and support agreement with Parent substantially in the form of Exhibit A
attached hereto (the "Support Agreement"); and

  

  

WHEREAS, the Company, Merger Sub, and Parent desire to make certain
representations, warranties, covenants and agreements in connection with the
Merger, and also to prescribe various conditions to the Merger.

  

  

NOW, THEREFORE, in consideration of the foregoing and the respective
representations, warranties, covenants and agreements set forth herein, the
parties hereto agree as follows:

  

  

ARTICLE 1 
 

  

  

THE MERGER

  

  

1.01 The Merger. At the Effective Time (as defined in Section 1.02), subject
to the terms and conditions of this Agreement and in accordance with the
relevant provisions of the DGCL, Merger Sub shall be merged with and into the
Company (the "Merger"). Following the Merger, the separate corporate existence
of Merger Sub shall cease, and the Company shall continue as the surviving
corporation (sometimes hereinafter referred to as the "Surviving Corporation")
and shall continue to be governed by the Laws (as defined in Section 3.06) of
the State of Delaware.

  

  

1.02 Effective Time. Subject to the provisions of this Agreement, on the
Closing Date, the Company shall file with the Secretary of State of the State
of Delaware a certificate of merger (the "Certificate of Merger") executed in
accordance with the relevant provisions of the DGCL. The Merger shall become
effective upon the filing of the Certificate of Merger or at such later time
as is agreed to by the parties hereto and specified in the Certificate of
Merger (the time at which the Merger becomes effective is herein referred to
as the "Effective Time").

  

  

1.03 Effects of the Merger. The Merger shall have the effects set forth
herein, in the Certificate of Merger and in the DGCL. Without limiting the
generality of the foregoing, and subject thereto, at the Effective Time, all
the properties, rights, privileges, powers and franchises of the Company and
Merger Sub shall vest in the Surviving Corporation, and all debts, liabilities
and duties of the Company and Merger Sub shall become the debts, liabilities
and duties of the Surviving Corporation. At and after the Effective Time, the
officers and directors of the Surviving Corporation shall be authorized to
execute and deliver, in the name and on behalf of the Company or Merger Sub,
any deeds, bills of sale, assignments or assurances and to take and do, in the
name and on behalf of the Company or Merger Sub, any other actions and things
to vest, perfect or confirm of record or otherwise in the Surviving
Corporation any and all right, title and interest in, to and under any of the
rights, properties or assets of the Company and Merger Sub.

  

   
 

 

 

 

  

 

2  

  

 

 

 

   
 

1.04 Certificate of Incorporation and Bylaws of the Surviving Corporation.

  

  

(a) Subject to the requirements of Section 5.06, at the Effective Time, the
certificate of incorporation of the Surviving Corporation shall be amended and
restated in its entirety to read as the certificate of incorporation of Merger
Sub, except that the name of the Surviving Corporation shall not be amended
and, as so amended and restated, shall be the certificate of incorporation of
the Surviving Corporation until thereafter further amended as provided therein
or by applicable Law.

  

  

(b) Subject to the requirements of Section 5.06, at the Effective Time, the
bylaws of the Surviving Corporation shall be amended and restated in its
entirety to read as the bylaws of Merger Sub, except that the name of the
Surviving Corporation shall not be amended and, as so amended and restated,
shall be the bylaws of the Surviving Corporation until thereafter further
amended as provided therein or by applicable Law.

  

  

1.05 Directors and Officers. The directors and officers of Merger Sub
immediately prior to the Effective Time shall be the initial directors and
officers of the Surviving Corporation and shall hold office until their
respective successors are duly elected and qualified, or their earlier death,
resignation or removal, in accordance with applicable Law and the Surviving
Corporation's certificate of incorporation and bylaws.

  

  

1.06 Closing. Subject to the conditions contained in this Agreement and unless
this Agreement shall have been terminated in accordance with Article VII, the
closing of the Merger (the "Closing") shall take place (a) at the offices of
Weil, Gotshal and Manges LLP, 767 Fifth Avenue, New York, New York at 10:00
a.m., on the Business Day that is most promptly practicable following the date
of the satisfaction (or waiver if permissible) of all of the conditions set
forth in Article 6 (other than those conditions that by their nature are to be
satisfied at the Closing, but subject to the satisfaction or waiver of such
conditions), but in no event later than the second (2nd) Business Day
following such date or (b) at such other place and time and/or on such other
date as the Company and Parent may agree in writing. The date on which the
Closing occurs is hereinafter referred to as the "Closing Date."

  

  

ARTICLE 2 
 

  

  

EFFECT OF THE MERGER ON THE CAPITAL STOCK

  

OF THE COMPANY AND MERGER SUB

  

  

2.01 Effect on Shares of Capital Stock.

  

  

(a) Common Shares of the Company. As of the Effective Time, by virtue of the
Merger and without any action on the part of the holder of any Common Shares,
the Company, Parent or Merger Sub, each Common Share that is issued and
outstanding immediately prior to the Effective Time (other than (i) Dissenting
Shares, and (ii) Common Shares to be canceled pursuant to Section 2.01(b))
shall be automatically canceled and extinguished and converted into the right
to receive $11.00 per share in cash (the "Merger Consideration"), payable to
the holder thereof, without interest or dividends thereon, less any applicable
withholding of Taxes (as defined in Section 3.13(g)), in the manner provided
in Section 2.03. All such Common Shares, when so converted, shall no longer be
outstanding and each holder of such Common Shares shall cease to have any
rights with respect thereto, except the right to receive the Merger
Consideration. Prior to the Effective Time, the Company shall take all
actions, if any that are necessary to give effect to the transactions
contemplated by this Section 2.01(a).

  

   
 

 

 

 

  

 

3  

  

 

 

 

   
 

(b) Cancellation of Certain Common Shares. As of the Effective Time, by virtue
of the Merger and without any action on the part of the holder of any Common
Shares, the Company, Parent or Merger Sub, each Common Share that is owned by
the Company as treasury stock or otherwise owned by Merger Sub or Parent shall
automatically be canceled and shall cease to exist, and no cash or other
consideration shall be delivered or deliverable in exchange therefor.

  

  

(c) Capital Stock of Merger Sub. As of the Effective Time, by virtue of the
Merger and without any action on the part of the holders of Merger Sub common
stock, the Company, Parent or Merger Sub, each share of common stock, par
value $0.001 per share, of Merger Sub ("Merger Sub Common Shares") issued and
outstanding immediately prior to the Effective Time shall be converted into
one validly issued, fully paid and non assessable share of common stock, par
value $0.001 per share, of the Surviving Corporation ("Surviving Corporation
Common Shares"), with the same rights, powers and privileges as the shares so
converted and shall constitute the only outstanding shares of capital stock of
the Surviving Corporation. Each certificate that, immediately prior to the
Effective Time, represented issued and outstanding Merger Sub Common Shares
shall, from and after the Effective Time, automatically and without the
necessity of presenting the same for exchange, represent the shares of the
Surviving Corporation capital stock into which such shares have been converted
pursuant to the terms hereof; provided, however, that the record holder
thereof shall receive, upon surrender of any such certificate, a certificate
representing the Surviving Corporation Common Shares into which the Merger Sub
Common Shares formerly represented thereby shall have been converted pursuant
to the terms hereof.

  

  

(d) Dissenting Shares. Notwithstanding anything in this Agreement to the
contrary, any Common Shares issued and outstanding immediately prior to the
Effective Time and held by a holder who has not voted in favor of the Merger
(a "Dissenting Stockholder") and who has properly demanded appraisal for such
Common Shares in accordance with the DGCL (each, a "Dissenting Shares") shall
not be converted into a right to receive the Merger Consideration at the
Effective Time in accordance with Section 2.01(a) hereof, but shall represent
and become the right to receive such consideration as may be determined to be
due to such Dissenting Stockholder pursuant to the Laws of the State of
Delaware, unless and until such holder fails to perfect or withdraws or
otherwise loses such holder's right to appraisal and payment under the DGCL.
If a Dissenting Stockholder fails to perfect appraisal rights in accordance
with the DGCL, or if such holder withdraws or otherwise loses such holder's
right to appraisal, such former Dissenting Shares held by such holder shall be
treated as if they had been converted as of the Effective Time into the right
to receive, upon surrender as provided above, the Merger Consideration,
without any interest or dividends thereon, in accordance with Section 2.01(a).
The Company shall give Parent prompt notice of any demands received by the
Company for appraisal of Common Shares, withdrawals of such demands and any
other instruments served pursuant to the DGCL and received by the Company, and
Parent shall have the right to participate in and, after the Effective Time,
to direct, all negotiations and proceedings with respect to such demands. The
Company shall not, except with the prior written consent of Parent or as
required under the DGCL, make any payment with respect to any demands for
appraisal or offer to settle or settle any such demands.

  

   
 

 

 

 

  

 

4  

  

 

 

 

   
 

2.02 Equity Awards.

  

  

(a) Options.

  

  

(i) For purposes of this Agreement, the term "Option" means any option to
purchase or acquire Common Shares (other than the Warrants), including any
option granted under the Company's 1998 Stock Option Plan and 2006 Equity
Incentive Plan (as amended and restated February 26, 2009) (collectively, the
"Stock Plans").

  

  

(ii) As of the Effective Time, by virtue of the Merger and without any action
on the part of any holder thereof, each Option that is outstanding and
unexercised immediately prior to the Effective Time shall, to the extent then
unvested, become fully vested and exercisable and shall be canceled, in each
case, in accordance with and pursuant to the terms of the Stock Plans and
related award agreements under which such Options were granted. In
consideration of such cancellation, each holder of an Option that has a per-
share exercise price less than the Merger Consideration, if any, will be
entitled to receive in settlement of such Option as promptly as practicable
following the Effective Time, a cash payment from the Surviving Corporation,
subject to any required withholding of Taxes, equal to the product of (i) the
total number of Common Shares otherwise issuable upon exercise of such Option
and (ii) the Merger Consideration less the applicable exercise price per
Common Share of such Option (the "Option Consideration"). Any Option with a
per-share exercise price that equals or exceeds the Merger Consideration shall
be canceled and no payment shall be made in respect thereof.

  

  

(b) Restricted Stock. As of the Effective Time, each then-outstanding share of
restricted stock ("Restricted Stock"), including any Restricted Stock
previously issued by the Company pursuant to the terms of any of the Stock
Plans and/or any applicable restricted stock award or restricted stock
purchase agreement, shall be converted into the right to receive from the
Surviving Corporation, as promptly as practicable following the Effective
Time, an amount in cash equal to the Merger Consideration (the "Restricted
Stock Consideration"), less any applicable withholding Taxes, and when so
converted will be automatically canceled and will cease to exist.

  

   
 

 

 

 

  

 

5  

  

 

 

 

   
 

(c) Restricted Stock Units. As of the Effective Time, each then-outstanding
restricted stock unit (each, a "Restricted Stock Unit"), including any
Restricted Stock Unit previously issued by the Company pursuant to the terms
of any of the Stock Plans and/or any applicable restricted stock unit award,
shall be converted into the right to receive from the Surviving Corporation,
as promptly as practicable following the Effective Time, an amount in cash
equal to the Merger Consideration that the holder would have been entitled to
receive had such Restricted Stock Unit vested in full and settled immediately
prior to the Effective Time (the "RSU Consideration"), less any applicable
withholding Taxes, and when so converted will be automatically canceled and
will cease to exist.

  

  

(d) Warrants.

  

  

(i) For purposes of this Agreement, the term "Warrant" means any warrant to
purchase or acquire Common Shares issued pursuant to the: (A) Venture Lending
and Leasing IV, Inc. warrant agreement, dated December 27, 2004, (B) Steve M.
Parker warrant agreement, dated December 14, 2004 and (C) Lloyd Malchow
warrant agreement approved by the Company Board on October 6, 2004 (each, a
"Warrant Agreement").

  

  

(ii) As of the Effective Time, by virtue of the Merger and without any action
on the part of any holder thereof, each Warrant that is outstanding and
unexercised immediately prior to the Effective Time shall, to the extent then
unvested, become fully vested and exercisable and shall be canceled, in each
case, in accordance with and pursuant to the terms of any Warrant Agreement
and related award agreements under which such Warrants were granted. In
consideration of such cancellation, each holder of a Warrant that has a per-
share exercise price less than the Merger Consideration, if any, will be
entitled to receive in settlement of such Warrant, as promptly as practicable
following the Effective Time, a cash payment from the Surviving Corporation,
subject to any required withholding of Taxes, equal to the product of (i) the
total number of Common Shares otherwise issuable upon exercise of such Warrant
and (ii) the Merger Consideration less the applicable exercise price per
Common Share of such Warrant (the "Warrant Consideration"). Any Warrant with a
per-share exercise price that equals or exceeds the Merger Consideration shall
be canceled and no payment shall be made in respect thereof.

  

  

(e) Employee Stock Purchase Plan.

  

  

(i) The Company has taken all actions necessary and sufficient, including, in
accordance with Section 20(a) and Section 4 of the SenoRx, Inc. Employee Stock
Purchase Plan (the "Company ESPP"), to provide that no new Offering Period (as
defined in the Company ESPP) under the Company ESPP will commence on and after
May 15, 2010 (the date upon which the Offering Period underway as of the date
of this Agreement will end pursuant to the terms and conditions of the Company
ESPP), unless this Agreement is terminated pursuant to Article 7.

  

   
 

 

 

 

  

 

6  

  

 

 

 

   
 

(ii) Each Common Share purchased under the Company ESPP and outstanding prior
to the Effective Time will be treated as a Common Share in accordance with
Section 2.01.

  

  

(iii) No offering period under the Company ESPP shall commence on or after the
date of this Agreement. The Company shall take all actions necessary and
sufficient in accordance with applicable Law and the Company ESPP (including
delivering all required notices and passing necessary resolutions of the
Company Board and any applicable committee thereof) to effect the foregoing,
so that the Company ESPP shall terminate immediately prior to the Effective
Time. All amounts withheld by the Company on behalf of the participants in the
Company ESPP that have not been used to purchase Common Shares prior to the
Effective Time will be returned to the participants without interest pursuant
to the terms of the Company ESPP.

  

  

(f) Payment. Promptly following the Effective Time, but in no event more than
one (1) Business Day following the Effective Time, Parent shall deposit, or
Parent shall otherwise take all steps necessary to cause to be deposited, by
wire transfer of immediately available funds, with the Surviving Corporation,
cash in an aggregate amount equal to (A) the aggregate Option Consideration
payable to all holders of Options pursuant to Section 2.02(a)(ii) (the "Option
Fund"), (B) the aggregate Restricted Stock Consideration payable to all
holders of Restricted Stock pursuant to Section 2.02(b) (the "Restricted Stock
Fund"), (C) the aggregate RSU Consideration payable to all holders of
Restricted Stock Units pursuant to Section 2.02(c) (the "RSU Fund") and (D)
the aggregate Warrant Consideration payable to all holders of Warrants
pursuant to Section 2.02(d)(ii) (the "Warrant Fund"). The Option Fund, the
Restricted Stock Fund, the RSU Fund and the Warrant Fund shall not be used for
any other purpose except as provided in this Agreement.

  

  

(g) Company Action. Prior to the Effective Time, the Company shall take all
actions necessary and sufficient in accordance with applicable Law, the
Company ESPP, the Stock Plans and, as applicable, the terms of each Option
award agreement, Warrant Agreement, Restricted Stock award or purchase
agreement and Restricted Stock Unit award agreement (including delivering all
required notices and passing necessary resolutions of the Company Board and
any applicable committee thereof), in each case, to give effect to the
transactions contemplated by this Agreement (including this Section 2.02).
Without limiting the foregoing, the Company shall take all actions necessary
to ensure that the Company will not, at the Effective Time, be bound by any
options, stock appreciation rights, restricted stock rights, restricted stock
units, phantom equity awards, warrants or other rights or agreements which
would entitle any Person, other than Parent and its subsidiaries, to own any
equity interest in the Surviving Corporation or to receive any payment in
respect thereof. The Company shall take all actions necessary and sufficient
to terminate the Company ESPP and all of its Stock Plans, such termination to
be effective at the Effective Time.

  

   
 

 

 

 

  

 

7  

  

 

 

 

   
 

2.03 Payment for Common Shares in the Merger.

  

  

(a) Prior to the Effective Time, Merger Sub shall appoint a commercial bank or
trust company reasonably acceptable to the Company to act as exchange and
paying agent, registrar and transfer agent (the "Agent") to facilitate the
receipt by the Company's stockholders of the Merger Consideration. Promptly
following the Effective Time, but in no event more than one (1) Business Day
following the Effective Time, Parent shall deposit, or Parent shall otherwise
take all steps necessary to cause to be deposited, by wire transfer of
immediately available funds, in trust with the Agent for the benefit of the
holders of Common Shares, cash in an aggregate amount equal to the product of
(i) the number of Common Shares issued and outstanding immediately prior to
the Effective Time and entitled to receive the Merger Consideration in
accordance with Section 2.01(a) and (ii) the Merger Consideration (the
"Payment Fund"). The Agent shall, pursuant to instructions provided by Parent,
make the payments provided for in Section 2.01 of this Agreement out of the
Payment Fund (it being understood that any and all interest earned on funds
made available to the Agent pursuant to this Agreement shall be turned over to
the Surviving Corporation). The Payment Fund shall not be used for any other
purpose except as provided in this Agreement.

  

  

(b) As promptly as reasonably practicable after the Effective Time, the
Surviving Corporation shall cause the Agent to mail to each Person who was, as
of immediately prior to the Effective Time, a holder of record of Common
Shares (i) a letter of transmittal (which shall be in customary form) which
shall specify that delivery shall be effected, and risk of loss and title to
the certificates representing the Common Shares (the "Certificates") or
uncertificated Common Shares represented by book entry ("Uncertificated
Shares") shall pass, only upon proper delivery of the Certificates or transfer
of the Uncertificated Shares to the Agent and (ii) instructions for use in
surrendering such Certificates or transfer of the Uncertificated Shares and
receiving the Merger Consideration in respect thereof.

  

  

(c) Upon (i) surrender of a Certificate for cancellation to the Agent,
together with such letter of transmittal validly executed and duly completed
in accordance with the instructions thereto or (ii) compliance with the
reasonable procedures established by the Agent for delivery of Uncertificated
Shares, the holder of such Certificate or Uncertificated Share shall be
entitled to receive, in exchange therefor, in the case of Common Shares (other
than Dissenting Shares or Common Shares to be canceled pursuant to Section
2.01(b)), cash in an amount equal to the product of (i) the number of Common
Shares formerly represented by such Certificate or Uncertificated Shares, as
applicable, and (ii) the Merger Consideration, which amount shall be paid by
the Agent by check in accordance with the instructions provided by such
holder. No interest or dividends will be paid or accrued on the consideration
payable upon the surrender of any Certificate or transfer of any
Uncertificated Share. In the event of a transfer of ownership of Common Shares
that is not registered in the transfer records of the Company, payment of the
Merger Consideration in respect of the applicable Common Shares may be made to
a Person (other than the Person in whose name the Certificate surrendered or
the Uncertificated Shares so transferred is registered) if such Certificate
shall be properly endorsed or otherwise in proper form for transfer or such
Uncertificated Shares shall be properly transferred. The Person requesting
such payment shall pay any transfer or other Taxes required by reason of the
payment of the Merger Consideration in respect thereof or such Person shall
establish to the satisfaction of the Surviving Corporation that such Tax has
been paid or is not applicable. Until surrendered or transferred, as the case
may be, in accordance with the provisions of this Section 2.03, each
Certificate or Uncertificated Share (other than those representing Dissenting
Shares or Common Shares to be canceled pursuant to Section 2.01(b)) shall
represent, for all purposes, only the right to receive cash in an amount equal
to the product of (i) the number of Common Shares formerly represented by such
Certificate or Uncertificated Shares, as applicable and (ii) the Merger
Consideration, without any interest or dividends thereon.

  

   
 

 

 

 

  

 

8  

  

 

 

 

   
 

(d) The consideration issued upon the surrender of Certificates or transfer of
Uncertificated Shares in accordance with this Agreement shall be deemed to
have been issued in full satisfaction of all rights pertaining to such Common
Shares formerly represented thereby. After the Effective Time, there shall be
no transfers on the stock transfer books of the Surviving Corporation of any
Common Shares that were outstanding immediately prior to the Effective Time.
If, after the Effective Time, Certificates or Uncertificated Shares are
presented to the Surviving Corporation, they shall be canceled and exchanged
as provided in this Article 2.

  

  

(e) Any portion of the Payment Fund (including any amounts that may be payable
to the former stockholders of the Company in accordance with the terms of this
Agreement) that remains unclaimed by the former stockholders of the Company
upon the nine (9) month anniversary of the Closing Date shall be returned to
the Surviving Corporation upon demand and any former stockholders of the
Company who have not theretofore complied with this Article 2 shall thereafter
look, subject to Section 2.03(f), to the Surviving Corporation only as general
unsecured creditors thereof for payment of any Merger Consideration, without
any interest or dividends thereon, that may be payable in respect of each
Common Share held by such stockholder. Following the Closing, the Agent shall
retain the right to invest and reinvest the Payment Fund, on behalf of the
Surviving Corporation, in securities listed or guaranteed by the United States
government or as otherwise directed by the Surviving Corporation, and the
Surviving Corporation shall receive the interest earned thereon. Nothing
contained in this Agreement and no investment losses resulting from the
investment of the Payment Fund shall diminish the rights of any holder of
Common Shares to receive the Merger Consideration as provided in this
Agreement.

  

  

(f) None of Parent, Merger Sub, the Company or the Agent shall be liable to a
holder of Certificates, Uncertificated Shares or any other Person in respect
of any cash delivered to a public official pursuant to any applicable
abandoned property, escheat or similar Law. If any Certificates shall not have
been surrendered or any Uncertificated Shares shall not have been transferred
by the sixth (6th) anniversary of the Closing Date (or immediately prior to
such earlier date on which any Merger Consideration, dividends (whether in
cash, stock or property) or other distributions with respect to Common Shares
in respect of such Certificate or Uncertificated Share would otherwise escheat
to or become the property of any Governmental Authority (as defined in Section
3.06(b)), any such shares, cash, dividends or distributions in respect of such
Certificate or Uncertificated Share shall become, to the extent permitted by
applicable Law, the property of the Surviving Corporation, free and clear of
all Claims (as defined in Section 3.10) or interests of any Person previously
entitled thereto.

  

   
 

 

 

 

  

 

9  

  

 

 

 

   
 

(g) In the event any Certificate shall have been lost, stolen or destroyed,
upon the making of an affidavit (in form and substance acceptable to the
Surviving Corporation) of that fact by the Person (who shall be the record
owner of such Certificate) claiming such Certificate to be lost, stolen or
destroyed and, if required by the Agent, the posting by such Person of a bond
in such amount as the Agent may direct as indemnity against any Claim that may
be made against it with respect to such Certificate, the Agent will issue in
exchange for such lost, stolen or destroyed Certificate the Merger
Consideration deliverable in respect of the Common Shares formerly represented
by such Certificate as contemplated by this Article 2.

  

  

(h) Each of the Agent, the Surviving Corporation and Parent shall be entitled
to deduct and withhold from the consideration otherwise payable to any holder
of Common Shares, Options, Restricted Stock, Restricted Stock Units or
Warrants pursuant to this Agreement such amounts as may be required to be
deducted or withheld with respect to the making of such payment under the
Internal Revenue Code of 1986, as amended (the "Code"), or any applicable
provision of state, local or non-U.S. Law. To the extent that amounts are so
deducted or withheld and paid over to the appropriate taxing authority by the
Agent, the Surviving Corporation or Parent, such amounts shall be treated for
all purposes of this Agreement as having been paid to such former holder of
Common Shares, Options, Restricted Stock, Restricted Stock Units or Warrants,
provided that the withheld amounts are actually remitted to the appropriate
taxing authority.

  

  

ARTICLE 3 
 

  

  

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

  

  

Except (i) as set forth in the Company Disclosure Schedule (the "Company
Disclosure Schedule") delivered to Parent on the date of this Agreement or
(ii) as set forth in the SEC Reports filed by the Company with the SEC between
December 31, 2008 and the date of this Agreement (other than any "risk factor"
disclosure or any other forward looking statements set forth therein), the
Company represents and warrants to each of Parent and Merger Sub as follows:

  

   
 

 

 

 

  

 

10  

  

 

 

 

   
 

3.01 Organization and Qualification. The Company is a corporation duly
organized, validly existing and in good standing under the Laws of the State
of Delaware and has all requisite corporate power and authority to carry on
its business as currently being conducted. The Company is duly qualified or
licensed as a foreign corporation to do business, and is in good standing (to
the extent applicable), in each jurisdiction where the nature of its business
makes such qualification or licensing necessary, except where the failure to
be so qualified or licensed and in good standing (to the extent applicable)
would not have a Company Material Adverse Effect. As used in this Agreement,
the term "Company Material Adverse Effect" means any fact, circumstance,
effect, event, change or occurrence that, individually or in the aggregate
with all other facts, circumstances, effects, events, changes or occurrences
(i) has, or would reasonably be expected to have, a material adverse effect on
the business, assets, condition (financial or otherwise) or results of
operations of the Company, or (ii) would prevent or have a material adverse
effect on the ability of the Company to consummate the Merger in accordance
with the terms of this Agreement, other than with respect to the foregoing
clauses (i) and (ii), resulting from or arising out of any Excluded Matter. As
used in this Agreement, "Excluded Matter" means any one or more of the
following: (A) any fact, circumstance, effect, event, change or occurrence
relating to local, regional, national or foreign political, economic or
financial conditions or resulting from or arising out of developments or
conditions in credit, currency, capital, securities or other financial
markets, including caused by acts of terrorism or war (whether or not
declared) or any material worsening of such conditions existing as of the date
of this Agreement; (B) any fact, circumstance, effect, event, change or
occurrence generally affecting the industries in which the Company operates;
(C) any fact, circumstance, effect, event, change or occurrence resulting from
any hurricane, earthquake or other natural disasters, weather conditions or
other force majeure events; (D) any change, in and of itself, in the share
price or trading volume of the Common Shares, provided that this clause (D)
shall not preclude any fact, circumstance, effect, event, change or occurrence
that may have contributed to or caused such changes from being taken into
account in determining whether a Company Material Adverse Effect has occurred,
unless such fact, circumstance, effect, event, change or occurrence is itself
not to be considered in the determination of whether a Company Material
Adverse Effect has occurred as described in any other clause in this
definition of "Excluded Matter"; (E) any fact, circumstance, effect, event,
change or occurrence resulting from a change after the date of this Agreement
in accounting rules or procedures announced with respect to United States
generally accepted accounting principles ("GAAP") or other accounting
standards (or the interpretation thereof), in each case, as applicable to the
financial statements of the Company, or a change after the date of this
Agreement in Laws (or the interpretation thereof); (F) any failure, in and of
itself, to meet any internal budgets, plans, projections or forecasts of the
Company's revenue, earnings or other financial performance or results of
operations, or any published financial forecasts or analyst estimates of the
Company's revenue, earnings or other financial performance or results of
operations or any change in analyst recommendations, for any period, provided
that this clause (F) shall not preclude any fact, circumstance, effect, event,
change or occurrence that may have contributed to or caused such failures from
being taken into account in determining whether a Company Material Adverse
Effect has occurred, unless such fact, circumstance, effect, event, change or
occurrence is itself not to be considered in the determination of whether a
Company Material Adverse Effect has occurred as described in any other clause
in this definition of "Excluded Matter"; (G) any fact, circumstance, effect,
event, change or occurrence attributable to the execution, performance or
announcement of this Agreement including (I) the identity of Parent, (II) the
loss or departure of officers or other employees of the Company, or (III) the
loss or diminution in the Company's relationships, contractual or otherwise,
with any of its customers, suppliers, distributors, landlords, licensors,
licensees or other business partners, provided that this clause (G) shall not
preclude any legal or contractual consequences of the execution of this
Agreement or the consummation of the Transactions from being taken into
account in determining whether a Company Material Adverse Effect has occurred;
(H) any action taken or failed to be taken by the Company at the request or
with the consent of Parent, that, if taken without the request or the consent
of Parent, would have been prohibited by the terms of this Agreement or (I)
any legal proceedings made or brought by any of the current or former
stockholders of the Company (on their own behalf or on behalf of the Company)
against the Company or any of its directors or officers, including legal
proceedings arising out of the Merger or in connection with any of the other
Transactions; but only in the case of the foregoing clauses (A), (B), (C) or
(E), to the extent such change or effect does not disproportionately adversely
affect the Company relative to the other industry participants.

  

   
 

 

 

 

  

 

11  

  

 

 

 

   
 

3.02 Charter Documents and Bylaws. The Company has heretofore made available
to Parent and Merger Sub a complete and correct copy, including all amendments
as in effect on the date hereof, of each of the certificate of incorporation
and the bylaws of the Company, which are in full force and effect as of the
date of this Agreement. The Company is not in violation of any of the
provisions of its certificate of incorporation or bylaws.

  

  

3.03 Capitalization.

  

  

(a) The authorized capital stock of the Company consists of 100,000,000 Common
Shares and 10,000,000 shares of preferred stock, par value $0.001 per share
(the "Preferred Stock"). As of May 4, 2010, (i) 17,552,560 Common Shares were
issued and outstanding, (ii) no shares of Preferred Stock were issued and
outstanding, (iii) 1,793,804 Common Shares were reserved for future issuance
pursuant to the Stock Plans, (iv) 2,750,824 Common Shares are subject to
outstanding Options, (v) 272,939 Common Shares are subject to Restricted Stock
Unit awards, (vi) 313,390 Common Shares are eligible for issuance under the
Company ESPP, (vii) 120 Common Shares are eligible for issuance under any
Restricted Stock award or purchase agreement and (viii) 218,600 Common Shares
are subject to outstanding Warrants. Except as set forth in this Section 3.03,
or as issued in compliance with the terms of Section 5.01, there are no
options, warrants, calls, subscriptions, or other rights, or other agreements
or commitments of any character relating to the issued or unissued capital
stock of the Company or obligating the Company to issue, transfer or sell any
shares of capital stock of, or other equity interests in, the Company. Section
3.03(a) of the Company Disclosure Schedule sets forth, as of the date of this
Agreement, the name of each holder of an Option, Warrant, Restricted Stock or
Restricted Stock Unit, and to the extent applicable, the Stock Plan pursuant
to which it was granted, the vesting schedule of each such Option, Warrant,
Restricted Stock or Restricted Stock Unit, together with the grant date,
exercise price and number of Common Shares issuable upon exercise of each such
Option or Warrant and settlement of each such Restricted Stock or Restricted
Stock Unit. All issued and outstanding Common Shares are duly authorized,
validly issued, fully paid, nonassessable and free of preemptive rights. All
Common Shares reserved for issuance as noted in clause (iii) above, when
issued in accordance with the respective terms thereof, are or will be duly
authorized, validly issued, fully paid and non-assessable and free of
preemptive rights and any lien, Claim, security interest or other charge,
title imperfection or encumbrance (each, a "Lien" and, collectively, "Liens")
(other than Liens created by the holder thereof) and will be issued in
compliance in all material respects with all applicable securities Laws. There
are no outstanding obligations of the Company to repurchase, redeem or
otherwise acquire any shares of capital stock of, or other equity interests
in, the Company, except to the extent Parent consents to such repurchase,
redemption or acquisition in accordance with Section 5.01.

  

  

(b) Other than the Support Agreements, there are no stockholders agreements,
voting trusts or other agreements or understandings entered into with the
Company or, to the Company's Knowledge, with any other Person, relating to
voting or disposition of any shares of capital stock of the Company or
granting to any Person or group of Persons the right to elect, or to designate
or nominate for election, a director to the Company Board.

  

   
 

 

 

 

  

 

12  

  

 

 

 

   
 

3.04 Authority Relative to this Agreement. The Company has all requisite
corporate power and authority to execute and deliver this Agreement, to
perform its obligations hereunder and, subject to the adoption of this
Agreement by the holders of a majority of the outstanding Common Shares
entitled to vote thereon (the "Stockholder Approval"), to consummate the
Transactions. The execution and delivery of this Agreement and the
consummation of the Merger and the other Transactions have been duly and
validly authorized by all necessary corporate action and no other corporate
proceedings on the part of the Company are necessary to authorize the
Company's execution and delivery of this Agreement or to consummate the
Transactions (other than Stockholder Approval and the filing or recordation of
the Certificate of Merger as required by the DGCL). This Agreement has been
duly and validly executed and delivered by the Company, and (assuming this
Agreement constitutes a valid and binding obligation of Merger Sub and Parent)
constitutes the legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, subject to
applicable bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium or other similar Laws relating to creditors' rights generally and
to general principles of equity.

  

  

3.05 Company Subsidiaries. The Company does not own, directly or indirectly,
any capital stock or other ownership interest in any Person.

  

  

  

   
 

 

 

 

  

 

13  

  

 

 

 

   
 

3.06 No Violation; Required Filings and Consents.

  

  

(a) The execution and delivery by the Company of this Agreement does not, and
the performance of this Agreement by the Company and the consummation by the
Company of the Transactions will not: (i) conflict with or violate any
provision of the Company's certificate of incorporation or bylaws; (ii)
assuming that all consents, approvals, authorizations and other actions
described in Section 3.06(b) have been obtained or performed and all filings
and obligations described in Section 3.06(b) have been made or complied with,
conflict with or violate any material foreign or domestic (federal, state or
local) law, statute, treaty, ordinance, rule, regulation, Permit (as defined
in Section 3.15), license, injunction, writ, judgment, decree, directive or
Order (as defined in Section 3.08) (each, a "Law" and, collectively, "Laws")
or rule of the NASDAQ Global Market ("Nasdaq") applicable to the Company or by
which any asset of the Company is bound or affected; (iii) conflict with,
result in any breach of or constitute a default (or an event that with or
without notice or lapse of time or both would become a default) under, or give
to others any right of termination, amendment, acceleration or cancellation
of, or require any payment under, or give rise to a loss of any benefit to
which the Company is entitled under, any provision of any contract,
instrument, Permit, concession, franchise, license, loan or credit agreement,
note, bond, mortgage, indenture, lease or other property agreement,
partnership or joint venture agreement or other legally binding agreement,
whether oral or written (each, a "Contract" and, collectively, "Contracts"),
to which the Company is a party or otherwise applicable to the Company or its
properties or assets; or (iv) result in the creation or imposition of a Lien
(other than Permitted Liens) on any of the properties or assets of the
Company, except in the case of clauses (iii) and (iv) of this Section 3.06(a),
to the extent that any such conflict, violation, breach, default, right, loss
or Lien would not, individually or in the aggregate, have a Company Material
Adverse Effect.

  

  

(b) The execution and delivery by the Company of this Agreement does not, and
the performance of this Agreement and the consummation by the Company of the
Transactions will not, require any consent, approval, authorization or Permit
of, or filing with or notification to, any domestic (federal, state or local)
or foreign or multi-national government or governmental, regulatory or
administrative authority, agency, commission, board, bureau, quasi-
governmental organization, body (including notified bodies), court or
instrumentality or arbitrator of any kind ("Governmental Authority"), or any
other Person except (i) for applicable requirements, if any, of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), the Securities Act of
1933, as amended (the "Securities Act"), the Hart Scott Rodino Antitrust
Improvements Act of 1976, as amended (the "HSR Act"), and the rules and
regulations thereunder, any required consent, approval, authorization, Permit,
filing or notification pursuant to applicable foreign Antitrust Laws and
regulations, the applicable rules of Nasdaq and filing and recordation of
appropriate documents for the Merger as required by the DGCL, (ii) for any
applicable notification requirement with respect to the various transactions
contemplated under Section 2.02 and Section 2.03 with respect to the Stock
Plans and/or Benefit Plans and (iii) where the failure to obtain such
consents, approvals, authorizations or Permits, or to make such filings or
notifications, could not, individually or in the aggregate, reasonably be
expected to impair in any material respect the ability of the Company to
perform its obligations hereunder, or prevent or materially impede, interfere
with, hinder or delay the consummation of the Transaction.

  

   
 

 

 

 

  

 

14  

  

 

 

 

   
 

3.07 SEC Reports; Financial Statements; Internal Controls.

  

  

(a) Since March 29, 2007, the Company has timely filed and furnished all
forms, reports, statements, schedules, exhibits and other documents (including
forms, reports, statements, schedules, exhibits and other documents required
to be filed after the date of this Agreement, the "SEC Reports") with the
Securities and Exchange Commission (the "SEC") required to be filed by it
pursuant to the federal securities Laws and the SEC rules and regulations
thereunder. The SEC Reports (i) were prepared in all material respects in
accordance with the requirements of the Securities Act, the Exchange Act and
the Sarbanes-Oxley Act of 2002 (the "Sarbanes-Oxley Act") and the published
rules and regulations of the SEC thereunder, each as applicable to such SEC
Reports and (ii) did not contain as of the time they were filed or furnished
any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in
light of the circumstances under which they were made, not misleading. As of
the date of this Agreement, there are no outstanding or unresolved comments
issued by the staff of the SEC with respect to any of the SEC Reports. To the
Knowledge of the Company, none of the Company's SEC Reports filed on or prior
to the date hereof is the subject of ongoing SEC review or investigation.

  

  

(b) Each of the financial statements (including, in each case, any notes and
schedules thereto) of the Company included in the SEC Reports has been
prepared in all material respects in accordance with the published rules and
regulations of the SEC as at the date of the filing of such reports, has been
prepared in accordance with GAAP applied on a consistent basis throughout the
periods indicated (except as otherwise stated in such financial statements,
including the related notes) and fairly presents, in all material respects,
the financial position, results of operations and cash flows of the Company as
at the respective dates thereof and for the respective periods indicated
therein (subject, in the case of unaudited statements, to the absence of
complete footnote disclosure and to normal and recurring year end adjustments
described therein, none of which, individually or in the aggregate, has had,
is or would reasonably be expected to be material to the Company). The Company
does not have any Indebtedness, except as may be incurred in compliance with
Section 5.01.

  

  

(c) The Company does not have any material liabilities or obligations of any
kind or nature required to be reflected or reserved against on a balance sheet
prepared in accordance with GAAP, except liabilities or obligations (i) fully
reflected on or reserved against in the Company's balance sheet as of December
31, 2009 (the "Balance Sheet Date") included in the Company's SEC Reports
filed prior to the date of this Agreement, (ii) incurred after the Balance
Sheet Date in the ordinary course of business consistent with past practices
or (iii) incurred in connection with the Transactions or as required by the
terms of this Agreement.

  

  

(d) The Company is not a party to, and does not have any commitment to become
a party to, any joint venture, off-balance sheet partnership or any similar
Contract or arrangement (including any Contract or arrangement relating to any
transaction or relationship between the Company, on the one hand, and any
unconsolidated affiliate on the other hand), including any "off-balance sheet
arrangement" (as defined in Item 303(a) of Regulation S-K promulgated by the
SEC)).

  

   
 

 

 

 

  

 

15  

  

 

 

 

   
 

(e) The Company is not indebted to any director or officer of the Company
(except for amounts due as normal salaries and bonuses or in reimbursement of
ordinary business expenses and directors' fees, in each case, in the ordinary
course of business consistent with past practices) and no such Person is
indebted to the Company and, except as set forth in the SEC Reports filed
prior to the date of this Agreement, between the date of the Company's last
proxy statement filed with the SEC and the date of this Agreement, there have
been no other transactions of the type required to be disclosed pursuant to
Item 402 of Regulation S-K promulgated by the SEC.

  

  

(f) The Company has established and maintains "disclosure controls and
procedures" (as such term is defined in Rule 13a-15(e) or 15d-15(e)
promulgated by the SEC under the Exchange Act) reasonably designed to ensure
that all information (both financial and non-financial) relating to the
Company required to be disclosed by the Company in the SEC Reports (i) is
accumulated and communicated to the Company's principal executive officer and
its principal financial officer to allow timely decisions regarding required
disclosure and (ii) are effective to ensure that information is recorded,
processed, summarized and reported within the time periods specified in the
rules and forms of the SEC. The Company's principal executive officer and its
principal financial officer have disclosed, based on their most recent
evaluation, to the Company's auditors and the audit committee of the Company
Board (i) all significant deficiencies that have been identified in the design
or operation of internal controls which could adversely affect the Company's
ability to record, process, summarize and report financial data and have
identified for the Company's auditors any material weaknesses in internal
controls and (ii) any fraud, whether or not material, that involves management
or other employees who have a significant role in the Company's internal
controls.

  

  

(g) The management of the Company has completed its assessment of the
effectiveness of the Company's internal control over financial reporting in
compliance with the requirements of Section 404 of the Sarbanes-Oxley Act for
the year ended December 31, 2009, and such assessment concluded that such
controls were effective. To the Knowledge of the Company, there are no facts
or circumstances that would prevent the Company's principal executive officer
and principal financial officer from giving the certifications and
attestations required pursuant to the rules and regulations adopted pursuant
to Section 404 of the Sarbanes-Oxley Act, without qualification, when next
due.

  

  

(h) There are no amendments or modifications, which are or, to the Knowledge
of the Company, will be required to be filed with the SEC, but have not yet
been filed, to (i) agreements, documents or other instruments which previously
have been filed by the Company with the SEC pursuant to the Exchange Act or
(ii) the Company's SEC Reports. The Company has delivered or made available to
Parent true, correct and complete copies of all correspondence with the SEC
occurring since January 1, 2007 and prior to the date of this Agreement.

  

   
 

 

 

 

  

 

16  

  

 

 

 

   
 

(i) The audit committee of the Company Board has established "whistleblower"
procedures that meet the requirements of Exchange Act Rule 10A-3, and the
Company has made available to Parent true, complete and correct copies of such
procedures. No complaint seeking relief under Section 806 of the Sarbanes-
Oxley Act has been filed with the United States Secretary of Labor and, to the
Knowledge of the Company, no employee has threatened to file any such
complaint.

  

  

3.08 Compliance with Applicable Laws. The Company is in compliance with, and
is not in default or violation of, any Law, or any consent decree, executive
order or other order, whether temporary, preliminary or permanent
(collectively, "Order") applicable to it, or by which any of its properties or
assets are bound and the business operations of the Company have been
conducted in compliance with all Laws of each Governmental Authority; except,
in each case, for any such non compliance, defaults or violations that would
not, individually or in the aggregate, have a Company Material Adverse Effect.
Since January 1, 2007, the Company has not received written notice to the
effect that a Governmental Authority claimed or alleged that the Company was
not in compliance with all Laws and Orders applicable to the Company, any of
the Company's properties or assets or any of the Company's business
operations.

  

  

3.09 Absence of Certain Changes or Events. Except as otherwise contemplated by
this Agreement, since the Balance Sheet Date and prior to the date hereof, (i)
the Company has conducted its business in all material respects in the
ordinary course of business consistent with past practices, (ii) there has not
been a Company Material Adverse Effect and (iii) the Company has not taken or
permitted to occur any action that, were it to be taken from and after the
date of this Agreement without the approval of Parent, would constitute a
breach of Section 5.01(a).

  

  

3.10 Litigation. Section 3.10 of the Company Disclosure Schedule sets forth as
of the date of this Agreement (a) each claim, action, suit, demand, proceeding
or litigation (collectively, a "Claim") pending, (b) each investigation or
inquiry by a Governmental Authority in respect of which the Company has
received notice, whether written or oral, and (c) to the Company's Knowledge,
each Claim, investigation or inquiry threatened in writing, in each case,
against the Company or any of the Company's properties or assets, at law or in
equity. There is no Claim pending, no investigation or inquiry by a
Governmental Authority in respect of which the Company has received notice,
whether written or oral, and to the Company's Knowledge, no Claim,
investigation or inquiry threatened in writing, in each case, against the
Company, at law or in equity, that individually or in the aggregate, would
reasonably be expected to have a Company Material Adverse Effect. The Company
is not, as of the date of this Agreement, subject to any Order by or before
any Governmental Authority that is material to the Company. Since January 1,
2007, the Company has not been a defendant in any Claim or inquiry involving
product liability or warranty claims, in each case, with respect to the
Company's products, and since such date, to the Company's Knowledge, no such
Claim or inquiry has been threatened. There are no settlement or similar
agreements that contain an ongoing obligation of the Company. There is no
Claim pending or threatened by the Company against any third party.

  

   
 

 

 

 

  

 

17  

  

 

 

 

   
 

3.11 Information in Proxy Statement and Other Disclosure Documents.

  

  

(a) Each document required to be filed by the Company with the SEC in
connection with the Transactions (the "Company Disclosure Documents"),
including the proxy or information statement of the Company containing
information required by Regulation 14A under the Exchange Act (collectively
with all amendments and supplements thereto, the "Proxy Statement"), to be
filed with the SEC in connection with the Merger, will, when filed, comply as
to form in all material respects with the applicable requirements of the
Exchange Act. The representations and warranties contained in this Section
3.11(a) will not apply to statements included in or omissions from the Company
Disclosure Documents based upon information furnished to the Company in
writing by Merger Sub or Parent or any of their representatives specifically
for use therein.

  

  

(b) At the time the Proxy Statement or any amendment or supplement thereto is
first mailed to the stockholders of the Company, and at the time such
stockholders vote on adoption of this Agreement, the Proxy Statement, as
supplemented or amended, if applicable, will not contain any untrue statement
of a material fact or omit to state any material fact necessary to make the
statements made therein, in the light of the circumstances under which they
were made, not misleading. At the time of the filing of any Company Disclosure
Document other than the Proxy Statement and at the time of any distribution
thereof, such Company Disclosure Document will not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made therein, in the light of the circumstances under
which they were made, not misleading. The representations and warranties
contained in this Section 3.11(b) will not apply to statements included in or
omissions from the Company Disclosure Documents based upon information
furnished to the Company in writing by Merger Sub or Parent or any of their
representatives specifically for use therein.

  

  

3.12 Benefit Plans.

  

  

(a) Section 3.12(a) of the Company Disclosure Schedule contains a correct and
complete list of (i) all "employee benefit plans" (as defined in Section 3(3)
of the Employee Retirement Income Security Act of 1974, as amended ("ERISA"))
and (ii) all other employee benefit plans, programs, agreements, policies,
arrangements or payroll practices, including bonus plans, employment,
individual consulting or other compensation agreements, collective bargaining
agreements, equity or equity-based compensation, employee stock ownership,
employee loan, or deferred compensation arrangements, change in control,
termination, retention or severance plans or arrangements, pension plans,
supplemental retirement plans, individual account-based savings plans, profit-
sharing, retirement plans, severance pay, stock purchase, stock option,
welfare benefits, incentive compensation, retiree health insurance, retiree
life insurance, Section 125 flexible benefit, vacation pay, sick pay, salary
continuation for disability, hospitalization, medical insurance, life
insurance, educational and employee assistance plans and programs or other
fringe benefit plans, arrangements or practices, whether or not subject to
ERISA, oral or written, in each case of (i) and (ii), sponsored, maintained,
or contributed to by, or required to be contributed to by, the Company for the
benefit of any current or former director, officer, employee or independent
contractor of the Company, or to which the Company has or could have any
liability, contingent or otherwise, including as a result of its or their
ERISA Affiliates (the foregoing clauses (i) and (ii), collectively, the
"Benefit Plans").

  

   
 

 

 

 

  

 

18  

  

 

 

 

   
 

(b) The Company has made available to Parent true, correct and complete copies
of the following documents (or a description thereof to the extent no writing
exists), to the extent applicable, (i) all Benefit Plans, including any plan
documents and related trust documents, insurance contracts or other funding
arrangements, and all amendments thereto, (ii) the most recent Forms 5500 and
all schedules thereto, (iii) the most recent actuarial reports, (iv) the most
recent Internal Revenue Service determination letters and (v) the most recent
summary plan descriptions and any other material communications to current or
former directors, employees, officers or independent contractors regarding the
extent or level of benefits thereunder.

  

  

(c) All Benefit Plans intended to be qualified plans may either rely on
opinion letters issued for the form of plan or have been the subject of
favorable determination letters from the Internal Revenue Service to the
effect that such Benefit Plans are qualified and exempt from federal income
Taxes under Section 401(a) and 501(a), respectively, of the Code. No such
determination letter has been revoked and nothing has occurred with respect to
the operation of the Benefit Plans that could reasonably be expected to cause
the loss of such qualification or exemption, or the imposition of any material
liability, penalty or Tax under ERISA or the Code.

  

  

(d) None of the Benefit Plans is, and neither the Company nor any of its ERISA
Affiliates has in the last six (6) years maintained, contributed to, had an
obligation to contribute to, or had any liability in respect of, a Title IV
Plan. Each Benefit Plan and all related trusts, insurance Contracts and funds
has been maintained, funded and administered in all material respects in
accordance with the terms of such Benefit Plan and in compliance in all
material respects with the applicable provisions of ERISA, the Code and other
applicable Laws, and each Benefit Plan which is a "nonqualified deferred
compensation plan" subject to Section 409A of the Code has been established
and maintained in compliance, in all material respects, with Section 409A of
the Code. All payments (including payments to any participant (or their
beneficiaries) and premium payments) and contributions (including all employer
contributions and employee salary reduction contributions) required to have
been made under the terms of such Benefit Plan, under any funds or trusts
established under such Benefit Plan, any related insurance Contract or any
applicable Law, have been made by the due date thereof (including any valid
extension), and all payments and contributions for any period ending on or
before the Effective Time which are not yet due will have been paid or accrued
on the Company's balance sheet on or prior to the Effective Time.

  

  

(e) With respect to each Benefit Plan, (i) no Claims or inquires (other than
routine Claims or inquiries for benefits in the ordinary course of business
consistent with past practices) are pending, or to the Company's Knowledge,
threatened against the Benefit Plans, the assets of any of the trusts under
such plans or the plan sponsor or administrator, or against any fiduciary of
the Benefit Plans, in each case, with respect to the operation of the Benefit
Plans and (ii) to the Company's Knowledge, no facts or circumstances exist
that could give rise to any such Claims or inquiries.

  

   
 

 

 

 

  

 

19  

  

 

 

 

   
 

(f) The Company has no obligation to provide, nor do any of the Benefit Plans
provide, for post-employment health or life insurance, benefits or coverage
for any Person, except as specifically required under the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended ("COBRA"), or similar state Law
and at the sole expense of such Person.

  

  

(g) Each Option granted by the Company (i) was granted with a per share
exercise price equal to or greater than the per share fair market value of the
Company's underlying Common Shares on the date of grant thereof and no such
Option has a feature for the deferral of compensation, in each case, within
the meaning of Section 409A of the Code and the regulations and other guidance
issued thereunder ("Section 409A") or satisfies the "grandfather" rules for
stock options under Section 409A and (ii) which was intended to be an
incentive stock option (within the meaning of Section 422 of the Code) was
granted pursuant to a Benefit Plan which meets the requirements of Section 422
of the Code.

  

  

(h) Neither the execution and delivery of this Agreement nor the consummation
of the Transactions will, either alone or in connection with any other
event(s), (i) result in any payment becoming due to any current or former
director, officer, employee or independent contractor of the Company, (ii)
increase any amount of compensation or benefits otherwise payable under any
Benefit Plan, (iii) result in the acceleration of the time of payment, funding
or vesting of any benefits under any Benefit Plan, (iv) require any
contributions or payments to fund any obligations under any Benefit Plan, (v)
limit the right to merge, amend or terminate any Benefit Plan (except any
limitations imposed by Law, if any) or (vi) give rise to any amount that would
not be deductible under Section 280G of the Code. No Benefit Plan or other
agreement with any employee provides for a "gross-up" or similar payment in
respect of any Taxes that may become payable under Section 409A or Section
4999 of the Code.

  

  

(i) There is no Contract or other arrangement or plan (including any Benefit
Plan) by or with the Company covering any Person that, individually or
collectively, could give rise to the payment of any amount by the Company that
would not be deductible by the Company or the Surviving Corporation by reason
of Section 162(m) of the Code.

  

  

(j) Each current or former director, officer, employee or independent
contractor of the Company has been, and is, properly classified as an
employee, independent contractor or consultant under applicable Law, except
for any failure to be so classified that would not give rise to a material
liability to the Company. The Company has no direct or indirect liability with
respect to any misclassification of any current or former director, officer,
employee or independent contractor of the Company as an independent contractor
rather than as an employee, as a part-time employee rather than a full-time
employee, or with respect to any employee leased from another employer, except
for any such liability that would not give rise to a material liability to the
Company.

  

   
 

 

 

 

  

 

20  

  

 

 

 

   
 

(k) No Benefit Plan is maintained outside the jurisdiction of the United
States, or covers any employee residing or working outside the United States.

  

  

3.13 Taxes.

  

  

(a) The Company has (i) timely filed or caused to be filed all material Tax
Returns required to be filed by it, and each such Tax Return has been prepared
in substantial compliance with all applicable Laws and is true and correct in
all material respects; (ii) timely paid all material Taxes (as defined in
Section 3.13(g)) required to be paid and has accrued all Taxes that are not
yet due and payable on the Company's financial statements in accordance with
GAAP; and (iii) not incurred any material liability for Taxes subsequent to
the date of the most recent financial statements contained in the SEC Reports
other than in the ordinary course of business consistent with past practices.

  

  

(b) (i) No material Tax Return of the Company is under audit or examination by
any taxing authority, and no written (or, to the Knowledge of the Company,
oral) notice of such an audit or examination or any other audit or examination
with respect to material Taxes has been received by the Company; (ii) each
material deficiency resulting from any audit or examination relating to Taxes
by any taxing authority has been paid, and no other deficiency for any
material amount of Tax has been assessed in writing, or to the Company's
Knowledge has been threatened, by any taxing authority against the Company
that is still outstanding, except in each case for deficiencies currently
being diligently contested in good faith by appropriate proceedings and for
which adequate reserves, as applicable, have been established in the Company's
financial statements in accordance with GAAP; (iii) there are no material
Liens for Taxes upon the assets of the Company, except Liens relating to
current Taxes not yet due and payable or otherwise being diligently contested
in good faith by appropriate proceedings and for which adequate reserves, as
applicable, have been established in the Company's financial statements in
accordance with GAAP; (iv) the Company has not consented to extend the time in
which any Tax may be assessed or collected by any taxing authority; and (v) no
written (or, to the Knowledge of the Company, oral) claim has been made by any
taxing authority in a jurisdiction where the Company does not file Tax Returns
that the Company is or may be subject to taxation in that jurisdiction, other
than such claims which would not reasonably be expected to be material.

  

  

(c) The Company (i) has not been a member of an affiliated group filing a
consolidated, combined or unitary income Tax Return, (ii) is not party to or
bound by any material Tax allocation or Tax sharing agreement with any Persons
and (iii) has no liability for the Taxes of any Person under Treas. Reg. 
1.1502-6 (or any similar provision of state, local or foreign Law), as a
transferee or successor, by Contract, or otherwise.

  

   
 

 

 

 

  

 

21  

  

 

 

 

   
 

(d) The Company will not be required to include any material item of income
in, or exclude any material item of deduction from, taxable income for any
taxable period (or portion thereof) ending after the Closing Date as a result
of any change in method of accounting for a taxable period ending on or prior
to the Closing Date under Section 481(a) of the Code (or any corresponding or
similar provision of state, local or foreign income Tax Law).

  

  

(e) The Company has not been a United States real property holding corporation
within the meaning of Section 897(c)(2) of the Code during the applicable
period specified in Section 897(c)(1)(A)(ii) of the Code.

  

  

(f) The Company has not been a "controlled corporation" or a "distributing
corporation" in any distribution occurring during the two (2) year period
ending on the date hereof that was purported or intended to be governed by
Section 355 of the Code (or any similar provision of state, local or foreign
Law). All material amounts of Tax required to be withheld by the Company have
been timely withheld and paid over to the appropriate taxing authority. The
Company has not engaged in any "reportable transaction" within the meaning of
Treas. Reg.  1.6011-4(b). The Company possesses all Tax Returns and work
papers necessary to support any carry-forwards of the Company's net operating
losses, net capital losses, Tax credits and other applicable Tax benefits.

  

  

(g) As used in this Agreement, the terms: (i) "Tax" (and, with correlative
meaning, "Taxes") means: (A) any federal, state, local or non U.S. net income,
gross income, gross receipts, windfall profit, severance, property,
production, sales, use, license, excise, franchise, employment, payroll,
withholding, alternative or add on minimum, ad valorem, value added, transfer,
stamp or environmental tax, or any other tax of any kind whatsoever, together
with any interest or penalty or addition to tax imposed by any Governmental
Authority; and (B) any liability in respect of any items described above as a
transferee or successor, pursuant to Treas. Reg.  1.1502-6 (or any similar
provision of Law), or as an indemnitor, guarantor, surety or in a similar
capacity or otherwise; and (ii) "Tax Return" means any report, return,
estimate, claim for refund or other information or document supplied, filed or
required to be supplied to or filed with a federal, state, local or foreign
taxing authority in connection with Taxes (including any amendments thereof or
attachments thereto).

  

  

3.14 Intellectual Property.

  

  

(a) Section 3.14(a) of the Company Disclosure Schedule sets forth a complete
and correct list as of the date of this Agreement of: (i) all patented or
registered Proprietary Rights owned by the Company, including Internet domain
name registrations; (ii) all pending patent applications or other applications
for registration of Proprietary Rights owned by the Company; and (iii) all
trade names and corporate names used by the Company. Section 3.14(a) of the
Company Disclosure Schedule further lists the jurisdictions in which each such
item giving rise to Proprietary Rights has been issued, registered, or in
which any such application for such issuance and registration has been filed,
the current status of each such item, including a listing of all necessary
actions or required payments that the Company must take within ninety (90)
days following the Closing Date to obtain, maintain, perfect or renew said
listed item and the registration or application date, as applicable.

  

   
 

 

 

 

  

 

22  

  

 

 

 

   
 

(b) Section 3.14(b) of the Company Disclosure Schedule sets forth a complete
and correct list as of the date of this Agreement of: (i) information
technology products used in the operations of the Company ("IT Software") for
which the Company paid more than $3,000 in the aggregate in license fees or
pays more than $1,000 in annual support fees; and (ii) all other licenses or
similar Contracts or arrangements, in effect as of the date of this Agreement,
in which the Company is a licensee of Proprietary Rights, or pursuant to which
Proprietary Rights are or have been sold, assigned or otherwise conveyed or
provided to the Company (other than for IT Software for which the Company paid
$3,000 or less in the aggregate in license fees or pays $1,000 or less in
annual support fees), and a correct and complete list of all patents and
pending patent applications subject to such licenses.

  

  

(c) Section 3.14(c) of the Company Disclosure Schedule sets forth a complete
and correct list as of the date of this Agreement of all licenses or similar
Contracts or arrangements in which the Company is a licensor of Proprietary
Rights, including reseller agreements, other than customer Contracts entered
into in the ordinary course of business consistent with past practices.

  

  

(d) The Company owns and possesses all right, title and interest in and to the
Proprietary Rights set forth in Section 3.14(a) of the Company Disclosure
Schedule, and has a valid and enforceable right to use Proprietary Rights
licensed from third parties pursuant to the Contracts set forth in Section
3.14(b) of the Company Disclosure Schedule. To the Company's Knowledge, the
Company owns and possesses all right, title and interest in and to, or
otherwise has rights to, all Proprietary Rights (including those set forth in
Section 3.14(a) and Section 3.14(b) of the Company Disclosure Schedule)
necessary and material for the operation of the Company's business as
currently conducted or as currently proposed to be conducted, free and clear
of all Liens (collectively, the "Company Proprietary Rights").

  

  

(e) The Company: (i) to the Company's Knowledge, has not infringed,
misappropriated, diluted or otherwise conflicted with, and the operation of
the Company's business as currently conducted does not infringe,
misappropriate, dilute or otherwise conflict with, any Proprietary Rights of
any third party; (ii) is not aware, to the Company's Knowledge, of any facts
that indicate a likelihood of any of the foregoing; and (iii) has not received
any notices regarding any of the foregoing (including any cease and desist
demands or offers to license any Proprietary Rights from any third party, or
any requests for indemnification from customers or distributors).

  

   
 

 

 

 

  

 

23  

  

 

 

 

   
 

(f) (i) No loss or expiration of any of the Company Proprietary Rights is
threatened, pending or reasonably foreseeable, except for pending patent or
trademark applications that may not result in issuance or patents expiring at
the end of their statutory terms (and not as a result of any act or omission
by the Company); (ii) to the Company's Knowledge, all of the Company
Proprietary Rights are valid and enforceable and none of the Company
Proprietary Rights has been misused by the Company; (iii) no Claim by any
third party contesting the validity, enforceability, use or ownership of any
of the Company Proprietary Rights has been made, is currently outstanding or
is, to the Company's Knowledge, threatened, and there are, to the Company's
Knowledge, no grounds for the same; (iv) the Company has taken all
commercially reasonable action to maintain and protect all of the Company
Proprietary Rights and will continue to use commercially reasonable efforts to
maintain and protect all of the Company Proprietary Rights prior to the
Closing so as not to adversely affect the validity or enforceability thereof,
except where the failure to maintain or protect any of the Company Proprietary
Rights would not have a Company Material Adverse Effect; (v) the Company has
not disclosed or allowed to be disclosed any of its trade secrets or material
confidential information to any third party without first entering into a
confidentiality agreement with such third party containing at least industry-
standard terms and conditions governing the non-disclosure and use of the
Company's trade secrets or material confidential information by such third
party; (vi) the Company has a practice requiring all Persons who create,
invent or contribute to Company Proprietary Rights to execute an assignment
agreement and no material violation of such practice has occurred; and (vii)
to the Company's Knowledge, no third party has infringed, misappropriated,
diluted or otherwise conflicted with any of the Company Proprietary Rights and
the Company is not aware of any facts that indicate a likelihood of any of the
foregoing.

  

  

(g) No software embedded or integrated into any of the Company's products
contains any software governed, in whole or in part, by the terms of the GNU
General Public License or any other license requiring (as a license condition
or otherwise) the Company to disclose publicly source code to any software
embedded or integrated into any of the Company's products or requiring the
Company to grant or to surrender any rights in or to the software (including
intellectual property rights). The computer software, computer firmware,
computer hardware (whether general purpose or special purpose), and other
similar or related items of automated, computerized and/or software system(s)
that are used or relied on by the Company in the conduct of its business is
sufficient in all material respects for the current needs of such business;
provided, however, that nothing herein shall require the Company, during the
period prior to the Closing Date, to abstain from updating, upgrading and
expanding its information technology systems, as may be determined necessary
or prudent by the Company's management. The Company's right, title and
interest in and to any of the Company Proprietary Rights under any Contract
set forth in Section 3.14(b) of the Company Disclosure Schedule is not subject
to termination or any other material adverse effect on the account of the
consummation of the Transactions contemplated by this Agreement.

  

   
 

 

 

 

  

 

24  

  

 

 

 

   
 

(h) As used in this Agreement, the term "Proprietary Rights" means all of the
following in any jurisdiction throughout the world: (i) patents and patent
applications, including all reissues, division, renewals, reexaminations,
extension, divisionals, continuations, and continuations in part thereof and
patents issuing thereon; (ii) trademarks, service marks, trade dress, trade
names, corporate names, logos and slogans (and all translations, adaptations,
derivations and combinations of the foregoing), other source or business
identifiers, and Internet domain names, together with all goodwill associated
with each of the foregoing; (iii) copyrights and all mask work, database and
design rights, whether or not registered or published; (iv) registrations,
renewals, extensions, reversions, recordations, and applications for any of
the foregoing; (v) rights in trade secrets and confidential information
(including those pertaining to inventions, ideas, formulae, compositions, know
how, manufacturing and production processes and techniques (including
laboratory notebooks), research and development information, drawings,
specifications, designs, plans, proposals, technical data, financial, business
and marketing plans, and customer and supplier lists and related information);
and (vi) all other intellectual property rights protectable under applicable
Laws.

  

  

3.15 Licenses and Permits. The Company is in possession of and has obtained
all franchises, grants, authorizations, licenses, permits, easements,
variances, exceptions, consents, certificates, exemptions, 510(k) clearances,
approvals, declarations, registrations, filings and Orders of or required by
any Governmental Authority ("Permits") necessary for the Company to (a)
manufacture, market, sell, or distribute its products, (b) own, lease and
operate its properties and (c) carry on its business as it is currently being
conducted (collectively, the "Company Permits"), except for any Company Permit
where the failure to so possess or obtain would not be material to the
Company. No suspension, withdrawal, revocation or cancellation of any of the
Company Permits is pending or, to the Company's Knowledge, threatened, and the
Company is, and has since January 1, 2007 been, in compliance in all material
respects with the terms of all Company Permits. All of the Company Permits are
in full force and effect, except where the failure to be in full force and
effect would not have a Company Material Adverse Effect. None of the Company
Permits will be terminated or impaired or become terminable, in whole or in
part, as a result of the Transactions.

  

  

3.16 Material Contracts.

  

  

(a) Section 3.16(a) of the Company Disclosure Schedule lists as of the date of
this Agreement (1) all material Contracts (within the meaning of Item
601(b)(10) of Regulation S-K), including all amendments thereto, of the
Company that have not been filed as exhibits to the SEC Reports and (2) each
of the following Contracts to which the Company is a party:

  

  

(i) Contract that purports to limit, curtail or restrict the ability of the
Company or any of its future subsidiaries or existing or future affiliates to
compete in any geographic area or line of business or to solicit or hire any
person or restrict the Persons to whom the Company or any of its future
subsidiaries or existing or future affiliates may sell products or deliver
services;

  

   
 

 

 

 

  

 

25  

  

 

 

 

   
 

(ii) Contract relating to research and development and clinical trials
conducted or to be conducted for or on behalf of the Company;

  

  

(iii) customer Contract providing for or otherwise involving (x) the payment
of credits or rebates or (y) discounts or other similar allowances for
customers who purchased more than $25,000 of consumable products in the first
quarter of 2010 other than pursuant to the Company's published standard volume
discount schedule;

  

  

(iv) partnership or joint venture agreement or sharing of revenues, profits,
losses or liabilities or any other similar Contract;

  

  

(v) Contract for the acquisition, sale or lease of material properties or
assets (by merger, purchase or sale of stock or assets or otherwise) entered
into since January 1, 2007;

  

  

(vi) Contract with any (x) Governmental Authority or (y) director or officer
of the Company or any affiliate of the Company;

  

  

(vii) Medicare, Medicaid or other third-party payor reimbursement Contracts;

  

  

(viii) loan or credit agreement, mortgage, indenture, note or other Contract
or instrument evidencing Indebtedness by the Company or any Contract or
instrument pursuant to which Indebtedness may be incurred or is guaranteed by
the Company;

  

  

(ix) financial derivatives master agreement or confirmation, or futures
account opening agreements and/or brokerage statements, evidencing financial
hedging or similar trading activities;

  

  

(x) voting agreement, registration rights agreement or stockholders agreement;

  

  

(xi) mortgage, pledge, security agreement, deed of trust or other Contract
granting a Lien (other than Permitted Liens) on any property or assets of the
Company;

  

  

(xii) group purchasing organization, customer, client or supply (including
sole-source and single-source) Contract that is reasonably likely to involve
consideration in fiscal year 2010 or fiscal year 2011 in excess of $100,000;

  

  

(xiii) Contract (other than customer, client or supply Contracts) that is
reasonably likely to involve consideration (whether or not measured in cash)
in fiscal year 2010 or fiscal year 2011 in excess of $100,000;

  

   
 

 

 

 

  

 

26  

  

 

 

 

   
 

(xiv) collective bargaining Contract or other Contract with any labor union;

  

  

(xv) any Contract imposing any "standstill" obligation upon the Company or
upon any other party, other than in connection with a confidentiality
agreement entered into prior to the date of this Agreement with a party
considering a business combination transaction with the Company;

  

  

(xvi) consulting Contract;

  

  

(xvii) guarantees, suretyships, performance bonds to suppliers, Governmental
Authorities, banks or other Person;

  

  

(xviii) Contract that restricts or otherwise limits the payment of dividends
or other distributions on equity securities;

  

  

(xix) Contract that grants any Person other than the Company any (A) exclusive
license, supply, distribution or other rights, (B) "most favored nation"
rights or (C) exclusive rights to purchase any Company products;

  

  

(xx) to the extent material to the business or financial condition of the
Company (1) lease or rental Contract, (2) product design or development
Contract, (3) indemnification or contribution Contract, (4) merchandising,
sales representative or distribution Contract, (5) Contract granting a right
of first refusal or first negotiation or (6) manufacturing and production
Contract;

  

  

(xxi) Contract under which the consequences of a default or breach or the
early termination of which would reasonably be expected to have a Company
Material Adverse Effect; or

  

  

(xxii) commitment or agreement to enter into any of the foregoing.

  

  

The Contracts listed in (i) through (xxi) of Section 3.16(a) of the Company
Disclosure Schedule, together with the contracts filed as exhibits to the SEC
Reports and additional contracts of the type described in subparagraphs 2(i)
through 2(xxi) of this Section 3.16(a) entered into after the date of this
Agreement, are referred to collectively as the "Material Contracts".

  

  

(b) (i) The Company is not and, to the Company's Knowledge, no other party is,
in breach of or in default under any Material Contract in any material respect
and (ii) there has not occurred any event that, with or without the lapse of
time or giving of notice or both, would constitute such a breach of or default
under, any Material Contract in any material respect by the Company or, to the
Company's Knowledge, by any other party thereto. All Material Contracts are
valid and binding, in full force and effect in accordance with their
respective terms and enforceable against the Company and, to the Company's
Knowledge, the other parties thereto, in accordance with their respective
terms, subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other similar Laws relating to creditors' rights generally and
to the general principles of equity. Since January 1, 2007 the Company has not
received any Claim or threat that it has breached any of the terms and
conditions of any Material Contract in such a manner as would permit any other
party to cancel or terminate the same or would permit any other party to seek
damages from the Company under any Material Contract.

  

   
 

 

 

 

  

 

27  

  

 

 

 

   
 

(c) All Material Contracts, including all amendments thereto (within the
meaning of Item 601(b)(10) of Regulation S-K) of the Company that have been
filed as exhibits to the SEC Reports contain a correct and complete copy of
each exhibit and schedule attached thereto.

  

  

3.17 Environmental Laws. Except as would not have a Company Material Adverse
Effect:

  

  

(a) The Company is and since five (5) years prior to the date of this
Agreement, has been in compliance with all Environmental Laws, which
compliance includes obtaining, maintaining and complying with all licenses,
permits, authorizations of consents required by Environmental Laws for its
operations ("Environmental Permits") and no proceeding is pending or, to the
Company's Knowledge, threatened to revoke, materially modify or terminate any
such Environmental Permits;

  

  

(b) No Claim or investigation is pending or, to the Company's Knowledge,
threatened against the Company or any real property currently or formerly
owned, operated or leased by the Company alleging or otherwise concerning non-
compliance with, or potential or actual liability under, any Environmental
Laws;

  

  

(c) To the Company's Knowledge, no current facts or conditions exist with
regard to the Company or any real property currently or formerly owned,
operated or leased by or for the Company that would reasonably be expected to
result in the Company incurring material liability under any Environmental
Laws;

  

  

(d) The Company has provided to Parent and Merger Sub copies of all material
written environmental assessments, audits, investigations or other material
environmental reports and all material environmental correspondence or
materials relating to (i) the Company's operations, (ii) any real property
currently or formerly owned, operated or leased by or for the Company, in each
case, to the extent material and (iii) any material environmental,
occupational health or safety issues or liabilities of the Company, to the
extent such materials are in the possession, custody or control of the
Company.

  

  

For purposes of this Agreement, "Environmental Laws" shall mean any and all
applicable federal, national, state, provincial, local or foreign Laws and
Orders of any Governmental Authority pertaining to the environmental
pollution, the protection of the environment, natural resources or
occupational health and safety as it relates to exposure to hazardous or toxic
substances, materials or wastes.

  

   
 

 

 

 

  

 

28  

  

 

 

 

   
 

3.18 State Takeover Statutes. Assuming that the representations and warranties
of Parent and Merger Sub set forth in Section 4.09 are accurate, the Company
Board has taken all actions so that no "fair price", "moratorium", "control
share acquisition", "business combination" or other similar anti-takeover Laws
in the United States (including Section 203 of the DGCL) applicable to the
Company shall be applicable to the Merger or the other Transactions.

  

  

3.19 Opinion of Financial Advisor. The Company Board has received the written
opinion (the "Fairness Opinion") of Piper Jaffray and Co. (the "Financial
Advisor"), dated as of the date of this Agreement, to the effect that, as of
the date of this Agreement and based upon and subject to the factors and
assumptions set forth therein, the Merger Consideration to be received by the
holders of Common Shares (other than Parent or any of its affiliates) pursuant
to the Merger is fair to such holders from a financial point of view. A
correct and complete copy of the Fairness Opinion has been delivered to
Parent. The Company has been authorized by the Financial Advisor to permit the
inclusion of the Fairness Opinion and references thereto in the Proxy
Statement.

  

  

3.20 Brokers. Except for the engagement of the Financial Advisor, no broker,
finder, investment banker, financial advisor or other Person is entitled to
any broker's, finder's, financial advisor's or other similar fee or
commission, or the reimbursement of expenses, in connection with Transactions.
Prior to the execution hereof, the Company has furnished to Parent a complete
and correct copy of all Contracts between the Company and the Financial
Advisor pursuant to which the Financial Advisor would be entitled to any fees
or expenses or indemnification related to the Transactions.

  

  

3.21 Related Party Transactions. Except as set forth in the SEC Reports filed
prior to the date of this Agreement and the Support Agreement, between the
date of the Company's last proxy statement filed with the SEC and the date of
this Agreement, no event has occurred that would be required to be reported by
the Company pursuant to Item 404 of Regulation S-K promulgated by the SEC.

  

  

3.22 Properties and Assets. The Company has good and valid title to, or, in
the case of leased properties and assets, valid leasehold interests in, all of
its material tangible properties and assets, real and personal, used or held
for use in its business, free and clear of any Liens except for Permitted
Liens. For purposes of this Agreement, "Permitted Liens" shall mean (i) Liens
for Taxes not yet due and payable or which are otherwise being diligently
contested in good faith by appropriate proceedings and for which adequate
reserves, as applicable, have been established in the Company's financial
statements in accordance with GAAP; (ii) mechanics, carriers', workmen's,
warehouseman's, repairmen's, materialmen's or other Liens that are not yet due
or that are being contested in good faith and by appropriate proceedings;
(iii) leases, subleases and licenses (other than capital leases and leases
underlying sale and leaseback transactions); (iv) Liens imposed by applicable
Law (other than Tax Law); (v) pledges or deposits to secure obligations under
workers' compensation Laws or similar legislation or to secure public or
statutory obligations; (vi) pledges and deposits to secure the performance of
bids, trade contracts, leases, surety and appeal bonds, performance bonds and
other obligations of a similar nature, in each case, in the ordinary course of
business consistent with past practices; (vii) defects, imperfections or
irregularities in title, easements, covenants and rights of way (unrecorded
and of record) and other similar restrictions, and zoning, building and other
similar codes or restrictions, in each case, that do not adversely affect in
any material respect the current use of the applicable property owned, leased,
used or held for use by the Company; (viii) Liens the existence of which are
disclosed in the notes to the financial statements of the Company included in
the Company's

  

   
 

 

 

 

  

 

29  

  

 

 

 

   
 

Annual Report on Form 10-K for the fiscal year ended December 31, 2009 or
described in Section 3.22 of the Company Disclosure Schedule; (x) statutory,
common law or contractual liens of landlords; and (xi) Liens which do not,
individually or in the aggregate, materially interfere with or materially
impair the conduct of the business of the Company. The Company does not own
any real property. The real property listed in Section 3.22 of the Company
Disclosure Schedule constitutes all of the real property used or occupied by
the Company as of the date of this Agreement. The Company's buildings,
equipment and other tangible assets are in good operating condition (normal
wear and tear excepted) to carry on the Company's business in all material
respects as currently conducted. All material leases to which the Company is a
party are in good standing, valid and effective in accordance with their
respective terms, and there is not under any of such leases, any existing
default or event of default (or event which with or without notice or lapse of
time or both would constitute a default), except where the lack of such good
standing, validity and effectiveness or the existence of such default or event
of default could not reasonably be expected to, individually or in the
aggregate, materially interfere with or impair the operation of the business
of the Company.

  

  

3.23 Labor Matters. Except, in the case of clauses (g), (i), (j) and (k)
below, as would not result in material liability to the Company, (a) there is
no labor strike, dispute, slowdown, stoppage or lockout actually pending, or,
to the Company's Knowledge, threatened against the Company, and during the
past three (3) years there has not been any such action, (b) no union claims
to represent the employees of the Company, (c) the Company is not a party to
or bound by any collective bargaining or similar Contract with any labor
organization, or work rules or practices agreed to with any labor organization
or employee association applicable to employees of the Company, (d) none of
the employees of the Company is represented by any labor organization and the
Company does not have any Knowledge of any current union organizing activities
among the employees of the Company, (e) the Company is and has at all times
been in material compliance, and has no outstanding material liability with
respect to any non-compliance, with all applicable Laws respecting employment
and employment practices, terms and conditions of employment, wages, hours of
work and occupational safety and health, including all such Laws, regulations
and Orders relating to the Fair Labor Standards Act, WARN, collective
bargaining, discrimination, civil rights, workers' compensation and the
collection and payment of withholding and/or social security Taxes and any
similar Tax; (f) there has been no "mass layoff" or "plant closing" as defined
by WARN with respect to the Company within the six (6) months prior to
Closing, (g) the Company is not engaged in any unfair labor practices as
defined in the National Labor Relations Act or other applicable Law and there
is no pending, or to the Company's Knowledge, threatened unfair labor practice
charge or complaint against the Company before the National Labor Relations
Board or any similar state or foreign agency, (h) there is no grievance
arising out of any collective bargaining agreement, (i) no charges with
respect to or relating to the Company are pending before the Equal Employment
Opportunity Commission or any other agency responsible for the prevention of
unlawful employment practices, (j) since January 1, 2007, the Company has not
received written notice of the intent of any Governmental Authority
responsible for the enforcement of labor or employment Laws to conduct an
investigation with respect to or relating to the Company and to the Company's
Knowledge no such investigation is in progress and (k) there are no Claims
pending or, to the Company's Knowledge, threatened, in any forum by or on
behalf of any present or former employee of the Company alleging breach of any
express or implied Contract of employment, any Law governing employment or the
termination thereof or other discriminatory, wrongful or tortious conduct in
connection with the employment relationship. To the Company's Knowledge, as of
the date of this Agreement, no officer or other key employee of the Company is
subject to any noncompete, nonsolicitation, employment, consulting or similar
Contract relating to, affecting or in conflict with the present or proposed
business activities of the Company, except agreements between the Company and
its present and former officers and employees.

  

   
 

 

 

 

  

 

30  

  

 

 

 

   
 

3.24 Regulatory Matters.

  

  

(a) The Company is and, since January 1, 2007, has been in compliance, in all
material respects, with all applicable Laws administered or issued by the
United States Food and Drug Administration ("FDA") or any other Governmental
Authority having regulatory authority over the Company's products or
operations, including the following: (i) the Federal Food, Drug and Cosmetic
Act, as amended, and the regulations promulgated thereunder; (ii) any
applicable FDA investigational device exemption, premarket approval or 510(k)
premarket notification; (iii) European Union Directive 93/42/EEC, as amended,
and any other applicable European Union legislation or national legislation of
the European Union Member States; and (iv) any applicable Canadian legislation
or Laws; except, in each case, for any such violations that would not have a
Company Material Adverse Effect.

  

  

(b) Since January 1, 2007, the Company has not received written notice of, nor
has the Company been subject to, any adverse inspectional finding, data
integrity review, investigation, penalty, fine, sanction, assessment, request
for corrective or remedial action, warning letter, regulatory letter, untitled
letter, FDA Form 483, or other written notice, communication, or
correspondence from the FDA or any other Governmental Authority alleging that
the Company is or was in violation of any Law, clearance, approval,
permission, authorization, consent, or exemption applicable to the research,
development, testing, manufacturing, packaging, labeling, marketing,
distribution, and/or sales activities conducted by the Company, or alleging
that the Company was or is the subject of any pending, threatened or
anticipated investigation, proceeding, review, or inquiry.

  

  

(c) None of the products developed, tested, manufactured, packaged, labeled,
marketed, or distributed by the Company have been recalled, whether voluntary
or otherwise, or are or have been subject to device removal or correction
reporting requirements, and the Company has not received written notice,
either completed or pending, of any proceeding seeking a recall, removal, or
corrective action of any products. No products are currently being considered
for recall or other field action by the Company, or to the Company\'s
Knowledge, by any Governmental Authority. Since January 1, 2007, the Company
has not, as a result of a failure to meet the applicable specifications,
applicable Laws or other regulatory requirements, experienced a manufacturing
hold, materials or product shortage, or any other event that materially
impacted the Company's ability to manufacture, process, distribute, supply,
import, market or sell any of its products. Each of the Company's products
have been and are being developed, manufactured, tested, packaged, labeled,
distributed, marketed, commercialized and sold in compliance in all material
respects with applicable Laws.

  

   
 

 

 

 

  

 

31  

  

 

 

 

   
 

(d) Neither the Company nor, to the Company's Knowledge, any employee or agent
of the Company has made an untrue statement of material fact or fraudulent
statement to FDA or any other Governmental Authority, or in any records and
documentation prepared or maintained to comply with the applicable Laws, with
respect to any product tested, manufactured, distributed, or sold by the
Company or the business of the Company, or failed to disclose a material fact
required to be disclosed to any Governmental Authority, or, to the Company's
Knowledge, has ever been investigated by the FDA, National Institutes of
Health, Office of the Inspector General for the Department of Health and Human
Services, Department of Justice or other comparable Governmental Authority for
data or healthcare program fraud.

  

  

(e) Neither the Company nor, to the Company's Knowledge, any employee or agent
of the Company have violated in any material respect or caused a material
violation of any federal or state health care fraud and abuse or false claims
statute or regulation, including the anti-kickback provisions of the Social
Security Act, 42 U.S.C.  1320a-7b(b), or have been excluded or threatened
with exclusion under Law, including under 42 U.S.C.  1320a-7 or relevant
regulations in 42 C.F.R. Part 1001, or assessed or threatened with assessment
of civil money penalties pursuant to 42 U.S.C. Part 1003. Neither the Company
nor, to the Company's Knowledge, any of its officers, directors and employees
have made or offered any payment, gratuity or other thing of value that is
prohibited by any Law to personnel of the FDA or any other Governmental
Authority

  

  

(f) There are not presently pending, nor, to Company's Knowledge, threatened
in writing, any civil, criminal or administrative Claims, hearings, notices of
violation, demand letters, or other written communications relating to any
alleged hazard or alleged defect in design, manufacture, materials or
workmanship, including any failure to warn or alleged breach of express or
implied warranty or representation, relating to any Company product, or
alleging that any Company product is otherwise unsafe or ineffective for its
intended use. Since January 1, 2007, the Company has not made any
modifications to any product specifically because of product liability,
regulatory, or other claims or communications concerning alleged hazards or
defects in such products.

  

   
 

 

 

 

  

 

32  

  

 

 

 

   
 

(g) To the Company's Knowledge, there is no pending, proposed or final
Medicare national or local coverage determination that, if finalized, would
materially restrict coverage for any Company product.

  

  

(h) To the extent applicable to the Company's business and to the Company's
Knowledge:

  

  

(i) The Company pays only reasonable and actual expenses for health care
professionals receiving training by the Company, and each such health care
professional has a bona fide need for such training;

  

  

(ii) The Company provides educational grants to third-parties educational
sponsors only if such sponsors have a genuine educational purpose or function
and only when (x) the educational gathering is primarily dedicated to
promoting objective scientific and educational activities and discourse; (y)
the Company does not select the attending health care professionals who are
attending the event; and (z) any meals sponsored or furnished by the Company
at the educational event are of modest value;

  

  

(iii) The Company pays health care professionals fair market value for their
services, plus reasonable and actual expenses, and only purchases such
services for which there is a commercially reasonable need for the services;

  

  

(iv) Any gift furnished by the Company has not exceeded $100 in value.

  

  

(v) All decisions on grants to health care professionals are made by Company
employees other than sales and marketing departments; and

  

  

(vi) All price concessions furnished by the Company are accurately reflected
in the invoice sent to the customer.

  

  

(i) Without limiting the generality of the foregoing, the Company is
conducting its business in compliance in all material respects with the Anti-
Kickback Statute (42 U.S.C.  1320a-7b), Civil Monetary Penalty Statute (42
U.S.C.  1320a-7a), the Stark Law (42 U.S.C.  1395nn), the False Claims Act
(31 U.S.C.  3729 et seq.) and all of the regulations promulgated under all
such statutes.

  

   
 

 

 

 

  

 

33  

  

 

 

 

   
 

3.25 Insurance. Section 3.25 of the Company Disclosure Schedule sets forth a
correct and complete list of all insurance policies maintained by the Company
and a description of the type of insurance covered by such policies, the
dollar limit of the policies and the annual premiums for such policies. All
premiums due and payable under all such policies have been paid and the
Company is otherwise in compliance in all material respects with the terms of
such policies. All such policies (i) have been issued by insurers which are
reputable and financially sound and (ii) are in full force and effect. The
Company is not in material breach or default, and the Company has not taken
any action or failed to take any action which, with or without the lapse of
time or giving of notice or both, would constitute such a breach or default,
or permit termination or modification, of any of such policies. The Company
has reported to its insurers all events that may give rise to a Claim under
all insurance policies. The Company does not maintain any material self-
insurance or co-insurance programs. As of the date of this Agreement, the
Company does not have any disputed Claim or Claims with any insurance provider
relating to any Claim for insurance coverage under any policy or insurance
maintained by the Company. No notice of cancellation or termination has been
received by the Company with respect to any of such policies. The consummation
of the Transactions will not, in and of itself, cause the revocation,
cancellation or termination of any such policy.

  

  

3.26 Foreign Corrupt Practices. The Company has conducted and is conducting
its business in material compliance with the Foreign Corrupt Practices Act of
1977, as amended, and the rules and regulations thereunder (the "FCPA") and
has instituted and maintained policies and procedures designed to ensure, and
which are reasonably expected to continue to ensure, continued compliance
therewith. Neither the Company nor, to the Company's Knowledge, any of its
directors, officers, agents, employees or any other Persons acting on its
behalf has, in connection with the operation of its business, (a) used any
corporate or other funds for unlawful contributions, payments, gifts or
entertainment, or made any unlawful expenditures relating to political
activity to government officials, candidates or members of political parties
or organizations, or established or maintained any unlawful or unrecorded
funds in violation of Section 104 of the FCPA, or any other similar applicable
Law or (b) paid, accepted or received any unlawful contributions, payments,
expenditures or gifts.

  

  

3.27 Export Controls. The Company has not, since January 1, 2007, violated, in
any material respect, any applicable U.S. Export and Import Laws, or made a
voluntary disclosure with respect to any violation of such Laws. The Company
(a) has been and is in compliance, in all material respects, with all
applicable Foreign Export and Import Laws since January 1, 2007, (b) to the
extent applicable, has prepared and applied for all import and export licenses
required in accordance with U.S. Export and Import Laws and Foreign Export and
Import Laws for the conduct of its business and (c) has at all times been in
compliance, in all material respects, with all applicable Laws relating to
trade embargoes and sanctions. No product, service or financing provided by
the Company has been, directly or indirectly, sold to, provided to, or
performed for or on behalf of Cuba, Iran, Libya, North Korea, Sudan, Syria or
any other country or Person against whom the United States maintains economic
sanctions or an arms embargo unless authorized by license or by Law. "Foreign
Export and Import Laws" means the Laws of a foreign government regulating
exports, imports or re-exports to or from the foreign country, including the
export or re-export of any goods, services or technical data. "U.S. Export and
Import Laws" means the Arms Export Control Act (22 U.S.C. 2778), the
International Traffic in Arms Regulations (ITAR) (22 CFR 120-130), the Export
Administration Act of 1979, as amended (50 U.S.C. 2401-2420), the Export
Administration Regulations (EAR) (15 CFR 730-774), the Foreign Assets Control
Regulations (31 CFR Parts 500-598), the Laws administered by Customs and
Border Protection (19 CFR Parts 1-199) and all other Laws of the United States
regulating exports, imports or re-exports to or from the United States,
including the export or re-export of goods, services or technical data from
the United States.

  

   
 

 

 

 

  

 

34  

  

 

 

 

   
 

3.28 Sales Tracings. The Company has requested sales tracing from its
international distributors.

  

  

ARTICLE 4 
 

  

  

REPRESENTATIONS AND WARRANTIES OF MERGER SUB AND PARENT

  

  

Each of Merger Sub and Parent represents and warrants to the Company as
follows:

  

  

4.01 Organization and Qualification. Each of Merger Sub and Parent is a
corporation duly organized, validly existing and in good standing (to the
extent such concept is relevant in such jurisdiction) under the Laws of its
jurisdiction of incorporation and has all requisite corporate or other power
and authority to carry on its business as currently being conducted. Each of
Merger Sub and Parent is duly qualified or licensed as a foreign corporation
to do business, and is in good standing, in each jurisdiction where the nature
of its business makes such qualification or licensing necessary, except where
the failure to be so qualified or licensed and in good standing would not,
individually or in the aggregate, have a Parent Material Adverse Effect. As
used in this Agreement, the term "Parent Material Adverse Effect" means any
fact, circumstance, effect, event, change or occurrence that would prevent or
have a material adverse effect on the ability of Parent and Merger Sub to
consummate the Merger in accordance with the terms hereof.

  

  

4.02 Charter Documents and Bylaws. Parent has heretofore made available to the
Company a complete and correct copy, including all amendments as in effect on
the date hereof, of each of the certificate of incorporation and the bylaws of
Parent, which are in full force and effect as of the date of this Agreement.
Parent is not in violation of any of the provisions of its certificate of
incorporation or bylaws. Parent has heretofore made available to the Company a
complete and correct copy, including all amendments as in effect on the date
hereof, of each of the certificate of incorporation and the bylaws of Merger
Sub, which are in full force and effect as of the date of this Agreement.
Merger Sub is not in violation of any of the provisions of its certificate of
incorporation or bylaws.

  

   
 

 

 

 

  

 

35  

  

 

 

 

   
 

4.03 Authority Relative to this Agreement. Each of Merger Sub and Parent has
all requisite corporate power and authority to execute and deliver this
Agreement, to perform its respective obligations hereunder and to consummate
the Transactions. The execution and delivery of this Agreement and the
consummation of the Merger and the other Transactions have been duly and
validly authorized by all necessary corporate action and no other corporate
proceedings on the part of Merger Sub or Parent are necessary to authorize
their execution and delivery of this Agreement or to consummate the
Transactions (other than the filing and recordation of the Certificate of
Merger as required by the DGCL). This Agreement has been duly and validly
executed and delivered by each of Merger Sub and Parent, and (assuming this
Agreement constitutes a valid and binding obligation of the Company)
constitutes the legal, valid and binding obligations of each of Merger Sub and
Parent, enforceable against them in accordance with its terms, subject to
applicable bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium or other similar Laws relating to creditors' rights generally and
to general principles of equity.

  

  

4.04 No Violation; Required Filings and Consents.

  

  

(a) The execution and delivery by each of Merger Sub and Parent of this
Agreement does not, and the performance of this Agreement and the consummation
by each of Merger Sub and Parent of the Transactions will not: (i) conflict
with or violate any provision of Parent's certificate of incorporation or
bylaws or conflict with or violate any provision of the certificate of
incorporation or bylaws or similar organizational documents of any subsidiary
of Parent (including Merger Sub), (ii) assuming that all consents, approvals,
authorizations and other actions described in Section 4.04(b) have been
obtained or performed and all filings and obligations described in Section
4.04(b) have been made or complied with, conflict with or violate any material
Law or rule of the New York Stock Exchange applicable to Parent or any of its
subsidiaries or by which any asset of Parent or any of its subsidiaries is
bound or affected, (iii) conflict with, result in any breach of or constitute
a default (or an event that with or without notice or lapse of time or both
would become a default) under, or give to others any right of termination,
amendment, acceleration or cancellation of, or require any payment under, or
give rise to a loss of any benefit to which Parent or any subsidiary of Parent
is entitled under, any provision of any Contract applicable to any of them or
their respective properties or assets which is material to Parent and its
subsidiaries, taken as a whole, or (iv) result in the creation or imposition
of a Lien (other than Permitted Liens) on any asset of Parent or any of its
subsidiaries, except in the case of clauses (iii) and (iv) of this Section
4.04(a), to the extent that any such conflict, violation, breach, default,
right, loss or Lien would not, individually or in the aggregate, have a Parent
Material Adverse Effect.

  

  

(b) The execution and delivery of this Agreement by each of Merger Sub and
Parent does not, and the performance of this Agreement and the consummation by
each of Merger Sub and Parent of the Transactions will not, require any
consent, approval, authorization or Permit of, or filing with or notification
to, any Governmental Authority or any other Person, except (i) for applicable
requirements, if any, of the Exchange Act, the Securities Act, the HSR Act and
the rules and regulations thereunder, any required consent, approval,
authorization, Permit, filing or notification pursuant to applicable foreign
Antitrust Laws and regulations, the applicable rules of the New York Stock
Exchange and filing and recordation of appropriate documents for the Merger as
required by the DGCL and (ii) where the failure to obtain such consents,
approvals, authorizations or Permits, or to make such filings or
notifications, could not, individually or in the aggregate, reasonably be
expected to impair in any material respect the ability of Parent or Merger Sub
to perform its obligations hereunder, or prevent or materially impede,
interfere with, hinder or delay the consummation of the Transaction.

  

   
 

 

 

 

  

 

36  

  

 

 

 

   
 

4.05 Financial Capability. Parent has, and will have at the Effective Time,
sufficient resources available to consummate the Merger on the terms and
conditions contained in this Agreement. Parent's and Merger Sub's obligations
hereunder are not subject to a condition regarding Parent's or Merger Sub's
obtaining funds to consummate the Transactions.

  

  

4.06 Brokers. The Company will not be responsible for any broker, finder,
financial adviser or other fee or commission in connection with the
Transactions based upon arrangements made by, or on behalf of, Parent or any
of its subsidiaries.

  

  

4.07 Litigation. There is no Claim or inquiry pending or, to Parent's
Knowledge, threatened against or affecting Parent that would have a Parent
Material Adverse Effect. There is no Order imposed upon Parent by or before
any Governmental Authority that would have a Parent Material Adverse Effect.

  

  

4.08 Information in Proxy Statement.

  

  

(a) Each document required to be filed by Parent with the SEC in connection
with the Transactions (the "Parent Disclosure Documents") will, when filed,
comply as to form in all material respects with the applicable requirements of
the Exchange Act.

  

  

(b) At the time the Proxy Statement or any amendment or supplement thereto is
first mailed to the stockholders of the Company, and at the time such
stockholders vote on adoption of this Agreement, the information furnished by
Merger Sub or Parent or any of their representatives specifically for use in
the Proxy Statement, as supplemented or amended, if applicable, will not
contain any untrue statement of a material fact or omit to state any material
fact necessary to make the statements made therein, in the light of the
circumstances under which they were made, not misleading. At the time of the
filing of any Parent Disclosure Document and at the time of any distribution
thereof, such Parent Disclosure Document will not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made therein, in the light of the circumstances under which they
were made, not misleading.

  

  

(c) The representations and warranties contained in Section 4.08(a) and
Section 4.08(b) will not apply to statements included in or omissions from the
Parent Disclosure Documents based upon information furnished to Parent in
writing by the Company or any of its representatives specifically for use
therein.

  

   
 

 

 

 

  

 

37  

  

 

 

 

   
 

4.09 Ownership of Common Shares. As of the date of this Agreement, neither
Parent nor any of its subsidiaries beneficially owns any Common Shares, other
than as set forth on Section 4.09 of the Parent Disclosure Schedule.

  

  

ARTICLE 5 
 

  

  

COVENANTS

  

  

5.01 Interim Operations.

  

  

(a) Except as otherwise expressly contemplated or permitted by this Agreement,
as set forth in Section 5.01 of the Company Disclosure Schedule, as required
by applicable Law, or as otherwise consented to in writing by Parent (which
consent shall not be unreasonably withheld, conditioned or delayed), the
Company covenants and agrees that during the period from the date of this
Agreement to the earlier of the Effective Time and the termination of this
Agreement in accordance with Article 7 hereof:

  

  

(i) the business and operations of the Company shall be conducted in the
ordinary course of business consistent with past practices (including the
timely filing with the SEC of all SEC Reports required to be filed by the
Company under the Exchange Act or the Securities Act from the date of this
Agreement to the Effective Time, and the compliance in all material respects
with the applicable requirements of the Exchange Act and Securities Act, as
the case may be, with respect to such SEC Reports) and the Company shall use
commercially reasonable efforts to preserve intact its current business
organization, keep available the services of its current officers and key
employees and preserve its relationships with its material customers,
suppliers, licensors, licensees and distributors;

  

  

(ii) the Company shall not (A) authorize for issuance, issue, deliver, sell or
agree or commit to issue, sell or deliver (whether through the issuance or
granting of options, commitments, subscriptions, rights to purchase or
otherwise), pledge or otherwise encumber any shares of its capital stock, any
other securities or any securities convertible into, or any rights, warrants
or options to acquire, any such shares, securities or convertible securities
or any other securities or equity equivalents (including stock appreciation
rights or phantom interests), except (x) for issuances of up to 33,750
Restricted Stock Units in the aggregate to (1) employees (other than officers)
hired after the date of this Agreement by the Company pursuant to customary
new hire packages entered into in the ordinary course of business consistent
with past practices and current market practices; provided, that the Company
shall not issue more than 5,000 Restricted Stock Units to any individual
employee, and (2) current employees (other than officers) of the Company;
provided, that the Company shall not issue more than 2,500 Restricted Stock
Units to any individual employee and such issuances shall be made in lieu of
ordinary course periodic issuances, (y) for issuances of Common Shares upon
the exercise of Options or Warrants, or settlement of Restricted Stock or
Restricted Stock Units, in each case, outstanding as of the date of this
Agreement or with respect to Restricted Stock Units, issued in compliance with
Section 5.01 and solely in accordance with the provisions of the Stock Plans
and/or Option agreements, Warrant Agreements or Restricted Stock award or
purchase agreements, as applicable, in each case, in effect on the date of
this Agreement or entered into in compliance with Section 5.01 or (z) for
issuances of Common Shares to participants in the Company ESPP pursuant to the
terms thereof and issued in compliance with the terms of this Agreement,
including Section 2.02(e), (B) repurchase, redeem or otherwise acquire any
shares of capital stock or other equity interests of the Company (including
securities exchangeable for, or options, warrants, calls, commitments or
rights of any kind to acquire, capital stock or other equity interests of the
Company) except for forfeitures of Common Shares issued pursuant to Restricted
Stock award or purchase agreements in effect on the date of this Agreement or
for Tax withholdings and exercise price settlements upon exercise of Options
or Warrants or with respect to Restricted Stock or Restricted Stock Units, in
each case, outstanding as of the date of this Agreement, (C) amend or
otherwise change its certificate of incorporation or bylaws, (D) split,
combine or reclassify any shares of its capital stock or (E) amend or
otherwise change the terms of any Options, Warrants, Restricted Stock Units or
Restricted Stock;

  

   
 

 

 

 

  

 

38  

  

 

 

 

   
 

(iii) the Company shall not (A) declare, set aside or pay any dividends on
(whether in cash, stock or other property), or make any other distributions in
respect of, any of its capital stock or (B) acquire or agree to acquire any
asset (except raw materials, inventory or supplies in the ordinary course of
business consistent with past practices and capital expenditures permitted by
Section 5.01(a)(xi)), business line, division, capital stock or other equity
interest of any Person;

  

  

(iv) except as otherwise permitted by Section 5.01(a)(ii), the Company shall
not (A) grant or agree to any increase, in any manner, in the compensation,
severance benefits or fringe benefits of, or pay any severance or bonus to,
any current or former director, officer or employee; provided that
compensation increases may be made only to employees (other than officers of
the Company) in the ordinary course of business consistent with past practices
and consistent with current market practices pursuant to the terms of any
Benefit Plan in effect on the date of this Agreement or entered into as
required by this Agreement, (B) enter into any new or amend, modify or
supplement any Contract (including any existing employment, consulting,
severance, termination, change of control or indemnification Contract),
transaction, commitment or arrangement with any current or former director,
officer, employee or other affiliate of the Company, provided that the Company
may enter into offer letters with new employees (other than officers)
providing for customary new hire packages consistent with the Benefit Plans in
effect on the date of this Agreement and may pay severance and provide other
termination benefits to employees (other than officers) of the Company as may
be required by the Benefit Plans in effect on the date of this Agreement, in
each case, in the ordinary course of business consistent with past practices
and current market practices, (C) except as may be required to comply with
applicable Law and except as provided or otherwise required by this Agreement
(including Section 2.02 and Section 5.17), become obligated under any Benefit
Plan that was not in existence on the date of this Agreement or amend, modify
or terminate any Benefit Plan or other employee benefit plan or any Contract,
arrangement, plan or policy for the benefit of any current or former director,
officer or employee in existence on the date of this Agreement or (D) except
as may be required to comply with applicable Law and except as provided or
otherwise required by this Agreement (including Section 2.02 and Section
5.17), pay any benefit not required by any plan or arrangement (including any
Benefit Plan) as in effect as of the date of this Agreement (including the
granting of, acceleration of exercisability of or vesting of stock options,
stock appreciation rights, restricted stock or restricted stock units;
provided, however, that the foregoing restriction shall not exclude the grant
of any stock options, restricted stock or restricted stock units granted (in
accordance with the terms of Section 5.01(a)(ii)) to any employee (other than
any officer) newly hired by the Company after the date of this Agreement);

  

   
 

 

 

 

  

 

39  

  

 

 

 

   
 

(v) the Company shall not sell, lease, license, mortgage or otherwise encumber
or subject to any Lien (other than Permitted Liens) or otherwise dispose of
any of its properties or assets that are material, individually or in the
aggregate, to the Company other than sales of inventory and other assets in
the ordinary course of business consistent with past practices;

  

  

(vi) the Company shall not (A) incur, assume, pre-pay, discharge or satisfy
any Indebtedness or enter into any Contract to incur, assume, pre-pay,
discharge or satisfy any Indebtedness, other than in the ordinary course of
business consistent with past practices pursuant to letters of credit, lines
of credit or other credit facilities or arrangements disclosed on Section
5.01(a)(vi) of the Company Disclosure Schedule, or guarantee, or agree to
guarantee, any such Indebtedness or obligation of another Person, or issue or
sell, or agree to issue or sell, any debt securities or options, warrants or
calls or rights to acquire any debt securities of the Company, guarantee any
debt securities of others, enter into any "keep well" or other Contract to
maintain any financial statement condition of another Person or enter into any
Contract or arrangement having the economic effect of any of the foregoing or
(B) make or forgive any loans, advances or capital contributions to,
guarantees for the benefit of, or investments in, any Person, other than cash
advances to the Company's employees for reimbursable travel and other business
expenses incurred in the ordinary course of business consistent with past
practices;

  

  

(vii) the Company shall not adopt or put into effect a plan of complete or
partial liquidation, dissolution, merger, consolidation, restructuring,
recapitalization or other reorganization of the Company;

  

  

(viii) the Company shall not enter into, or amend, modify, elect not to renew
or terminate or waive, release or assign any rights under, any Material
Contract, provided, however, that the Company may (A) amend, modify, elect not
to renew or terminate or waive, release or assign any rights under, any
Material Contract described in subparagraphs (ii), (iii), (vii), (xii),
(xiii), (xvi), (xix) and (xx) of Section 3.16(a)) in a manner that is not
adverse to the Company and which is in the ordinary course of business
consistent with past practices and (B) enter into any new Material Contract of
the type described in subparagraphs (ii), (iii), (vii), (xii), (xiii), (xvi),
(xix) and (xx) of Section 3.16(a) in the ordinary course of business
consistent with past practices.

  

   
 

 

 

 

  

 

40  

  

 

 

 

   
 

(ix) the Company shall not renew any of its distribution agreements for a
period of more than one (1) year from the date of expiration of the then
current term of any such distribution agreement;

  

  

(x) except for customer (including distribution) Contracts entered into in the
ordinary course of business consistent with past practices, the Company shall
not renegotiate or enter into any new Material Contract or arrangements
relating to any Proprietary Rights;

  

  

(xi) the Company shall not make any capital expenditure or commitments not
consistent with expenditures in the Company's capital budget for 2010 or 2011
provided to Parent prior to the date hereof and summarized in Section
5.01(a)(xi) of the Company Disclosure Schedule;

  

  

(xii) the Company shall not make any material changes in its standardized
sales terms and conditions other than in the ordinary course of business
consistent with past practices;

  

  

(xiii) the Company shall not enter into any settlement, conciliation or
similar Contract with any Governmental Authority;

  

  

(xiv) the Company shall not (A) settle or compromise any pending or threatened
Claim, except with respect to the settlement or compromise of any such Claim
(x) where the full amount paid or to be paid is covered by insurance coverage
maintained by the Company (subject to any applicable deductibles or retention
amounts) or (y) that is not covered by insurance and where the full amount
paid or to be paid does not exceed $25,000 individually, (B) change any of the
accounting policies, practices or procedures (including material Tax
accounting methods, periods, policies, practices or procedures) or any of its
methods of reporting income, deductions or other items for financial
accounting purposes, except as may be required as a result of a change in GAAP
enacted after the date of this Agreement or (C) except in the ordinary course
of business consistent with past practices, make, change or rescind any
material Tax election, enter into any material closing agreement relating to
Taxes, settle or compromise any material Tax liability, audit, Claim,
proceeding or assessment, file any material amended Tax Return, surrender any
right to claim a refund of material Taxes, or consent to any extension or
waiver of the limitation period applicable to any material Tax liability or
assessment;

  

   
 

 

 

 

  

 

41  

  

 

 

 

   
 

(xv) the Company shall not allow any material Company Proprietary Rights to
become abandoned or expired for failure to make required filings or pay
required fees;

  

  

(xvi) the Company shall not agree or commit to do any of the foregoing (other
than as permitted by clause (i) above); and

  

  

(xvii) the Company shall use commercially reasonable efforts to maintain its
inventory of supplies and components necessary for the manufacture of the
Company\'s products at adequate levels as required to operate the business.

  

  

(b) If the Company shall desire to take an action which would be prohibited
pursuant to Section 5.01(a) without the written consent of Parent, prior to
taking such action the Company shall request such written consent by sending
an email or facsimile to each of the following individuals, and may not take
such action until such consent (which consent shall not be unreasonably
withheld, conditioned or delayed) in writing has been received from any of the
following individuals:

  

  

Carl Rickenbaugh

  

Director, New Business Development

  

Email: carl.rickenbaugh@crbard.com

  

Fax: (480) 449-2569

  

  

John D. Kondrosky

  

Vice President and General Manager (Bard Canada, Inc.)

  

Email: john.kondrosky@crbard.com

  

  

In each case, with a copy (which shall not constitute notice) to:

  

Jim Beasley

  

Group Vice President

  

Email: jim.beasley@crbard.com

  

Fax: (480) 303-2725

  

  

5.02 Stockholders Meeting; Preparation of Proxy Statement.

  

  

(a) The Company, acting through the Company Board, shall, in accordance with
applicable Law and its certificate of incorporation and bylaws, duly call,
give notice of, convene and hold a special meeting of its stockholders (the
"Stockholders Meeting") as promptly as reasonably practicable following the
clearance by the SEC of the Proxy Statement for the purpose of considering and
voting upon the approval and adoption of this Agreement and such other matters
as may be necessary to effectuate the Transactions. The Company Board shall
(i) recommend to the stockholders of the Company the approval and adoption of
this Agreement, (ii) include in the Proxy Statement such recommendation of the
Company Board that the stockholders of the Company vote in favor of the
approval and adoption of this Agreement, (iii) use all reasonable efforts to
solicit such approval from the stockholders of the Company and (iv) not
withdraw or modify such favorable recommendation, provided however, if the
Company Board shall have effected a Recommendation Change in accordance with
Section 5.09(b), then the Company Board shall not be required to comply with
subparagraphs (i), (ii) and (iv) above. The Proxy Statement shall include a
copy of the Fairness Opinion and (subject to Section 5.09(b) hereof) the
recommendation by the Company Board of this Agreement and the Merger.

  

   
 

 

 

 

  

 

42  

  

 

 

 

   
 

(b) As promptly as reasonably practicable following the execution of this
Agreement, and in connection with the Stockholders Meeting, the Company shall
(i) prepare and, after prior review and approval by Parent and Merger Sub,
file with the SEC, use its commercially reasonable efforts to have cleared by
the SEC and thereafter mail to its stockholders as promptly as reasonably
practicable the Proxy Statement and all other proxy materials required in
connection with such meeting, (ii) notify Merger Sub and Parent of the receipt
of any comments from the SEC with respect to the Proxy Statement and of any
requests by the SEC for any amendment or supplement thereto or for additional
information and shall promptly provide to Merger Sub and Parent copies of all
correspondence between the Company or any representative of the Company and
the SEC, (iii) give Merger Sub and Parent and their counsel the opportunity to
review and comment on all amendments and supplements to the Proxy Statement
and all responses to requests for additional information and replies to
comments prior to their being filed with, or sent to, the SEC, (iv) use
commercially reasonable efforts to obtain the necessary approvals by its
stockholders of this Agreement and the Merger and (v) otherwise use its
commercially reasonable efforts to comply with all legal requirements
applicable to the Stockholders Meeting. If at any time prior to the Effective
Time any information should be discovered by any party hereto which should be
set forth in a supplement or amendment to the Proxy Statement in order to
ensure that the Proxy Statement would not include any misstatement of a
material fact or omit to state any material fact required to be stated therein
or necessary to make the statements made therein, in light of the
circumstances under which they were made, not misleading, the party that
discovers such information shall promptly notify the other parties hereto and,
to the extent required by applicable Law, an appropriate amendment or
supplement describing such information shall be promptly filed by the Company
with the SEC and disseminated by the Company to the stockholders of the
Company.

  

  

(c) Notwithstanding anything to the contrary contained in this Agreement, the
Company may adjourn or postpone the Stockholders Meeting (i) if, on the basis
of advice of outside counsel, it is necessary to do so in order to ensure that
any information requested specifically by the SEC or discovered by any party
hereto that should be set forth in a supplement or amendment to the Proxy
Statement so that the Proxy Statement would not include any misstatement of a
material fact or omit to state any material fact required to be stated therein
or necessary to make the statements made therein, in the light of the
circumstances under which they were made, not misleading, is provided to the
Company's stockholders or (ii) if as of the time for which the Stockholders
Meeting is originally scheduled there are insufficient Common Shares
represented (either in person or by proxy) to constitute a quorum necessary to
conduct the business to be conducted at the Stockholders Meeting.

  

   
 

 

 

 

  

 

43  

  

 

 

 

   
 

5.03 Filings and Consents.

  

  

(a) Each of Parent and Merger Sub (and their respective affiliates, if
applicable), on the one hand, and the Company, on the other hand, shall make
merger notification filings, at such times as are consistent with its legal
counsel's judgment (but in no event, in the case of clause (x) hereof, later
than twenty (20) Business Days following the execution and delivery of this
Agreement) with (x) the United States Federal Trade Commission (the "FTC") and
the Antitrust Division of the United States Department of Justice (the "DOJ")
relating to this Agreement and the transactions contemplated hereby as
required by the HSR Act, and (y) any foreign Governmental Authority that the
parties reasonably determine are necessary to be made under any other
Antitrust Laws. Each of Parent and the Company shall (i) cooperate and
coordinate with the other in the making of any filings or submissions that are
required to be made under any applicable Laws or Orders or requested to be
made by any Governmental Authority in connection with the Transactions, (ii)
supply the other or its outside counsel with any information that may be
required or requested by any Governmental Authority in connection with such
filings or submissions, and (iii) use all reasonable efforts to cause the
expiration or termination of the applicable waiting periods under any
applicable Laws or Orders as soon as reasonably practicable. If and to the
extent necessary to consummate and make effective the Transactions, to resolve
objections, if any, as the FTC, the DOJ, or any other Governmental Authority
may assert under any applicable Laws or Orders with respect to the
Transactions, and/or to avoid or eliminate each and every impediment under any
Law or Order that may be asserted by the FTC, the DOJ or any other
Governmental Authority with respect to the Transactions so as to enable
consummation of the Transactions in the most expeditious manner practicable,
Parent, the Company and their respective Subsidiaries shall promptly (and in
any event on or before six (6) months from the date of this Agreement) agree
to any sale, divestiture, license or other disposition of any business,
product line or asset of the Company that is not, taken as a whole or
individually, in the Parent's reasonable judgment, material to the Company's
business (including any hold separate order related to such sale, divestiture,
license or disposition), and the imposition of any restriction or limitation
on the ability of any of them to own or exercise control of such non-material
business, product line or asset of the Company (any such sale, divestiture,
license, disposition, hold separate, restriction or limitation, a "Non-
Material Divestiture"), and shall consummate any such Non-Material Divestiture
in the most expeditious manner practicable (and in any event on or before the
Expiration Date, consistent with Section 7.02(b)). Notwithstanding anything to
the contrary contained herein, nothing in this Agreement shall require (i)
Parent and/or Merger Sub (or their affiliates, if applicable) to sell, divest,
license, dispose of, hold separate, restrict or otherwise limit any of their
own businesses, product lines or assets or (ii) Parent, Merger Sub or the
Company to sell, divest, license, dispose of, hold separate, restrict or
otherwise limit any business, product line or asset of the Company which is,
taken as a whole or individually, in the Parent's reasonable judgment,
material to the Company's business.

  

   
 

 

 

 

  

 

44  

  

 

 

 

   
 

(b) Each of Parent and Merger Sub (and their respective affiliates, if
applicable), on the one hand, and the Company, on the other hand, shall
promptly inform the other of any communication from any Governmental Authority
regarding any of the Transactions in connection with any filings or
investigations with, by or before any Governmental Authority relating to this
Agreement or the Transactions, including any proceedings initiated by a
private party. If any party hereto or affiliate thereof shall receive a
request for additional information or documentary material from any
Governmental Authority with respect to the Transactions pursuant to the HSR
Act or any other Antitrust Laws with respect to which any such filings have
been made, then such party shall use its commercially reasonable efforts to
make, or cause to be made, as soon as reasonably practicable and after
consultation with the other party, an appropriate response to such request. In
connection with and without limiting the foregoing, to the extent reasonably
practicable and unless prohibited by applicable Law or by the applicable
Governmental Authority, the parties hereto agree to (i) give each other
reasonable advance notice of all meetings with any Governmental Authority
relating to this Agreement or the Transactions, (ii) keep the other party
reasonably apprised with respect to any communications with any Governmental
Authority regarding this Agreement or the Transactions, (iii) cooperate in the
filing of any analyses, presentations, memoranda, briefs, arguments, opinions
or other written communications explaining or defending this Agreement or the
Transactions, articulating any regulatory or competitive argument and/or
responding to requests or objections made by any Governmental Authority, and
(iv) provide each other (or counsel of each party, as appropriate) with copies
of all written communications to or from any Governmental Authority relating
to this Agreement or the Transactions. Any such disclosures or provisions of
information by one party to the other may be made on a counsel-only basis to
the extent required under applicable Law or as appropriate to protect
confidential business information.

  

  

5.04 Access to Information. From the date of this Agreement until the earlier
of the Effective Time or the date this Agreement is validly terminated in
accordance with Article 7, and subject to the requirements of any Law,
including (a) any Antitrust Law, (b) any applicable Law protecting the privacy
of employees and personnel files, (c) applicable undertakings given by the
Company to others requiring confidential treatment of documents and (d)
appropriate limitations on the disclosure of information to maintain attorney-
client privilege, the Company will, and will cause each of its affiliates, and
each of their respective officers, directors, employees, agents, counsel,
accountants, investment bankers, financial advisors and representatives
(collectively, the "Company Representatives") to, give Merger Sub and Parent
and their respective officers, directors, employees, agents, counsel,
accountants, investment bankers, financial advisors, representatives,
consultants and financing sources (collectively, the "Parent Representatives")
reasonable access, upon reasonable notice and during the Company's normal
business hours, to the offices and other facilities, to the officers and other
Company Representatives, and to the books and records of the Company and will
cause the Company Representatives to furnish or make available to Parent,
Merger Sub and the Parent Representatives such financial and operating data
and such other information with respect to the business and operations of the
Company as Parent, Merger Sub or the Parent Representatives may from time-to-
time reasonably request. Any investigation pursuant to this Section 5.04 and
information provided, made available or delivered to Parent, Merger Sub or any
Parent Representative pursuant to this Section 5.04 shall be conducted in a
manner that does not unreasonably interfere with the conduct of the business
of the Company or create a risk of damage or destruction to any property or
assets of the Company. Each of Parent and Merger Sub will, and will cause the
Parent Representatives to, hold any such information in confidence in
accordance with the terms of the Confidentiality Agreement (as defined below).
Except as otherwise agreed to by the Company, and notwithstanding termination
of this Agreement, the terms and provisions of the Confidentiality Agreement,
dated as of January 5, 2010 (the "Confidentiality Agreement"), between Parent
and the Company shall apply to all information furnished to any Parent
Representative by any Company Representative hereunder or thereunder. No
investigation pursuant to this Section 5.04 or information provided, made
available or delivered to Parent, Merger Sub or any Parent Representative
pursuant to this Section 5.04 shall affect any representations, warranties,
covenants, conditions, remedies or rights of the parties hereto contained in
this Agreement.

  

   
 

 

 

 

  

 

45  

  

 

 

 

   
 

5.05 Public Announcements. Promptly following the execution of this Agreement,
each of Parent and the Company may issue a press release, in each case, in a
form mutually agreed to by Parent and the Company announcing the execution of
this Agreement and the Transactions. Thereafter, each of Parent and Merger
Sub, on the one hand, and the Company, on the other hand, hereby agrees to (a)
consult promptly with the other party prior to issuing any press release or
otherwise making any public statement with respect to the Merger and the
Transactions and (b) provide to the other party for review a copy of any such
press release or statement, and shall not issue any such press release or make
any such public statement prior to such consultation and review by the other
party, unless required by applicable Law or rules and regulations of any
securities exchange, in which case the party shall use its commercially
reasonable efforts to allow the other party reasonable time to comment on such
release or announcement in advance of such issuance. Notwithstanding the
foregoing, the restrictions set forth in this Section 5.05 shall not apply to
any release or announcement made or proposed to be made by the Company
following a Recommendation Change.

  

  

5.06 Indemnification; Directors' and Officers' Insurance.

  

  

(a) The Surviving Corporation shall (and Parent shall cause the Surviving
Corporation to) cause the certificate of incorporation and the bylaws of the
Surviving Corporation to contain provisions with respect to indemnification,
advancement of expenses and director exculpation substantially similar to
those set forth in the Company's certificate of incorporation and bylaws as in
effect at the date of this Agreement (to the extent consistent with applicable
Law), which provisions shall not be amended, repealed or otherwise modified in
any manner that would adversely affect the rights thereunder of the Persons
who at any time prior to the Effective Time were entitled to indemnification,
advancement of expenses or exculpation under the Company's certificate of
incorporation or bylaws in respect of actions or omissions occurring at or
prior to the Effective Time (including the Transactions), unless otherwise
required by applicable Law. In addition, the Surviving Corporation shall (and
Parent shall cause the Surviving Corporation to) honor and fulfill in all
respects the obligations of the Company under those indemnification agreements
set forth on Section 5.06(a) of the Company Disclosure Schedule.

  

   
 

 

 

 

  

 

46  

  

 

 

 

   
 

(b) From and after the Effective Time and until the expiration of any
applicable statutes of limitation, to the fullest extent permitted by
applicable Law (but subject to Section 5.06(c)), the Surviving Corporation
shall (and Parent shall cause the Surviving Corporation to) indemnify, defend
and hold harmless each Person who is or has been prior to the date of this
Agreement or who becomes prior to the Effective Time an officer, director,
employee or agent of the Company (collectively, the "Indemnified Parties")
against all losses, Claims, damages, judgments, fines, fees and expenses
(including reasonable attorneys' fees and investigation expenses), liabilities
or amounts that are paid in settlement of, or otherwise incurred ("Losses")
(but only to the extent such Losses are not otherwise covered by insurance and
paid), in connection with any Claim, whether civil, criminal, administrative
or investigative, to which any Indemnified Party is or may become a party to
by virtue of his or her service as a present or former director, officer,
employee or agent of the Company and arising out of actual or alleged events,
actions or omissions occurring or alleged to have occurred at or prior to the
Effective Time (including the Transactions), in each case, to the fullest
extent permitted under the DGCL and provided in the Company's certificate of
incorporation and bylaws as in effect at the date of this Agreement (and shall
pay expenses in advance of the final disposition of the Claim(s) that are
reasonably incurred in defending any such Claim to each Indemnified Party to
the fullest extent permitted under the DGCL as provided in the Company's
certificate of incorporation and bylaws as in effect at the date of this
Agreement, upon receipt from the Indemnified Party to whom expenses are
advanced of the undertaking to repay such advances contemplated by the DGCL).

  

  

(c) Any Indemnified Party wishing to claim indemnification under this Section
5.06 after the Effective Time, upon learning of any such Claim, shall notify
the Surviving Corporation thereof; provided, however, the failure to so notify
the Surviving Corporation shall not relieve the Surviving Corporation from any
liability that the Surviving Corporation may have under this Section 5.06,
except to the extent such failure materially prejudices the Surviving
Corporation. In the event of any such Claim, the Surviving Corporation shall
have the right to assume the defense thereof and the Surviving Corporation
shall not be liable to such Indemnified Party for any legal expenses of other
counsel or any other expenses subsequently incurred by such Indemnified Party
in connection with the defense thereof, except that if the Surviving
Corporation elects not to assume such defense or if there is an actual or
potential conflict of interest between, or different defenses exist for the
Surviving Corporation and the Indemnified Party, the Indemnified Party may
retain counsel reasonably satisfactory to the Surviving Corporation and the
Surviving Corporation shall pay all reasonable fees and expenses of such
counsel for the Indemnified Party promptly as statements therefor are received
by the Surviving Corporation; provided, however, that (i) the Surviving
Corporation shall not, in connection with any such Claim or separate but
substantially similar Claims arising out of the same general allegations, be
liable for the fees and expenses of more than one separate firm of attorneys
at any time for all Indemnified Parties, (ii) the Surviving Corporation and
the Indemnified Parties will cooperate in the defense of any such matter,
(iii) the Surviving Corporation shall not be liable for any settlement
effected without its prior written consent and (iv) neither the Surviving
Corporation nor any of its affiliates (including Parent) shall settle or
otherwise compromise or consent to the entry of any judgment or otherwise seek
termination with respect to any Claim, investigation or inquiry for which
indemnification may be sought by an Indemnified Party under this Agreement,
without such Indemnified Party's prior written consent, unless such
settlement, compromise, consent or termination includes an unconditional
release of all Indemnified Persons from all liability arising out of such
claim, proceeding, investigation or inquiry; and provided, further, that the
Surviving Corporation shall not have any obligation hereunder to any
Indemnified Party if and when a court of competent jurisdiction shall
ultimately determine that the indemnification of such Indemnified Party in the
manner contemplated hereby is prohibited by applicable Law.

  

   
 

 

 

 

  

 

47  

  

 

 

 

   
 

(d) Effective upon the Effective Time, Parent shall cause to be purchased and
maintained a six (6) year "tail" prepaid liability insurance policy in respect
of acts or omissions occurring at or prior to the Effective Time, covering
each Person currently covered by the Company's directors' and officers'
liability insurance policy on terms, including with respect to coverage and
amount, no less favorable to such directors and officers than those of such
policy in effect on the date of this Agreement; provided, however, that in no
event shall Parent or the Surviving Corporation be required to expend for such
policies pursuant to this sentence an annual premium amount in excess of 200%
of the annual premiums currently paid by the Company for such insurance; and
provided, further, that if the annual premiums of such insurance coverage
exceed such amount, the Surviving Corporation shall obtain a policy with the
greatest coverage available for a cost not exceeding such amount.

  

  

(e) This Section 5.06 shall survive the consummation of the Merger and is
intended to be for the benefit of, and shall be enforceable by, the
Indemnified Parties referred to herein, their heirs, legal representatives,
successors, assigns and personal representatives and shall be binding on the
Surviving Corporation and its successors and assigns. The provisions of this
Section 5.06 are in addition to, and not in substitution for, any other rights
to indemnification that the Indemnified Parties, their heirs and personal
representatives may have by contract or otherwise.

  

  

(f) If the Surviving Corporation or any of its successors or assigns (i)
consolidates with or merges into any other Person and shall not be the
continuing or surviving corporation or entity of such consolidation or merger
or (ii) transfers or conveys all or substantially all of its properties and
assets to any Person, then, and in each case, as a condition to such
consolidation, merger, transfer or conveyance, proper provision shall be made
so that the successors and assigns of the Surviving Corporation shall assume
and agree to perform the obligations set forth in this Section 5.06.

  

   
 

 

 

 

  

 

48  

  

 

 

 

   
 

5.07 Further Assurances; Commercially Reasonable Efforts. Except as otherwise
provided in this Agreement, from the date of this Agreement until the earlier
of the termination of this Agreement pursuant to Article 7 or the Effective
Time, each of the parties hereto shall cooperate with the other parties and
use (and shall cause its subsidiaries and affiliates to use) commercially
reasonable efforts to take, or cause to be taken, all such actions, and to do,
or cause to be done, all such things as may be necessary or appropriate in
order to effectuate, as expeditiously as practicable, the Merger and the
Transactions, including causing the conditions to the Merger set forth in
Article 6 to be satisfied. Notwithstanding anything to the contrary herein,
the Company shall not be required prior to the Effective Time to pay any
consent fee, "profit sharing" payment or other consideration (including
increased rent or other payments), or to provide any additional security
(including a guaranty), to obtain the consent of any third party under any
Contract.

  

  

5.08 Third Party Standstill Agreements. From the date of this Agreement until
the earlier of the termination of this Agreement pursuant to Article 7 or the
Effective Time, (a) the Company shall not terminate, amend, modify or waive
any provision of any confidentiality or standstill Contract to which the
Company is a party (other than involving Parent or its affiliates) and (b) the
Company agrees to use commercially reasonable efforts to enforce the
provisions of any such Contracts, including seeking injunctions to prevent any
breaches of such agreements or to enforce specifically the terms and
provisions thereof in a court in the United States or any state thereof having
jurisdiction.

  

  

5.09 No Solicitation.

  

  

(a) From and after the date of this Agreement until the earlier of the
Effective Time or the termination of this Agreement pursuant to Article 7, the
Company and its officers and directors shall not, and the Company shall cause
the Company Representatives not to, (i) solicit, initiate or encourage
(including by way of furnishing information or assistance), or take any other
action to facilitate, any inquiry in connection with, or the making of any
proposal from any Person that constitutes, or would reasonably be expected to
lead to, an Acquisition Proposal (as defined in Section 5.09(f)), (ii)
maintain or continue, or enter into or participate in, any discussion or
negotiation with any Person (other than Merger Sub, Parent or any of the
Parent Representatives, as applicable) regarding an Acquisition Proposal, or
furnish to any Person (other than Merger Sub, Parent or any of the Parent
Representatives, as applicable) any information or otherwise cooperate in any
way with, or assist or participate in, any effort or attempt by any other
Person (other than Merger Sub, Parent or any of the Parent Representatives, as
applicable) to make or effect an Acquisition Proposal, or (iii) (A) except as
set forth in Section 5.09(b), withdraw or modify (in a manner adverse to
Parent) its approval or favorable recommendation of this Agreement and the
Merger, or approve, endorse or recommend an Acquisition Proposal or (B) enter
into any Contract, arrangement or understanding with respect to any
Acquisition Proposal (other than an Acceptable Confidentiality Agreement);
provided, however, that nothing contained in this Section 5.09 or any other
provision of this Agreement shall prohibit the Company Board, directly or
indirectly through the Company Representatives, prior to obtaining the
Stockholder Approval, from furnishing non-public information to, or entering
into or participating in discussions or negotiations with, any Person that
makes an unsolicited written, bona fide Acquisition Proposal (which did not
result from a breach of this Section 5.09) that provides for per Common Share
consideration that is greater than the Merger Consideration if (A) the Company
Board determines in good faith after consultation with its outside legal
counsel that failure to take such action would be inconsistent with its
fiduciary duties to the Company's stockholders under applicable Law, (B) prior
to entering into or participating in discussions with such Person, the Company
Board determines in good

  

   
 

 

 

 

  

 

49  

  

 

 

 

   
 

faith, after consultation with its outside legal counsel and the Financial
Advisor or other independent financial advisor of nationally recognized
reputation, that the Acquisition Proposal constitutes or would reasonably be
expected to lead to a Superior Proposal (as defined in Section 5.09(g)) and
(C) prior to furnishing any non-public information to, or entering into or
participating in discussions or negotiations with, such Person, (x) the
Company receives from such Person an executed confidentiality Contract (which
Contract shall be provided to Parent for informational purposes) with terms no
less favorable to the Company than those contained in the Confidentiality
Agreement, it being understood and agreed that such confidentiality Contract
need not contain a "standstill" or other similar provision that prohibits such
third party from making any proposal to acquire the Company, acquire
securities of the Company or nominate for election members of the Company
Board (such confidentiality Contract, an "Acceptable Confidentiality
Agreement") and (y) concurrently with its delivery to such Person, the Company
delivers to Parent and Merger Sub all such information not previously provided
to Parent and Merger Sub.

  

  

(b) Notwithstanding anything to the contrary contained in Section 5.02(a), the
Company Board may, prior to Stockholder Approval at the Stockholders Meeting,
(x) withdraw or modify (in a manner adverse to Parent) its approval or
recommendation of this Agreement and the Merger, (y) approve or recommend any
Acquisition Proposal or (z) recommend that the stockholders of the Company
reject this Agreement or the Merger (each Company Board action set forth in
clauses (x) through (z) of this Section is referred to herein as a
"Recommendation Change") if the Company Board determines in good faith, after
consultation with its outside legal counsel and the Financial Advisor or other
independent financial advisor of nationally recognized reputation, that such
Acquisition Proposal constitutes a Superior Proposal; provided, that prior to
reaching such conclusions (A) the Company Board shall have determined in good
faith, after consultation with its outside legal counsel, that the failure to
effect such Recommendation Change relating to such Superior Proposal would be
inconsistent with its fiduciary duties to the Company's stockholders under
applicable Law; (B) the Company shall have notified Parent in writing that it
intends to effect such Recommendation Change relating to such Superior
Proposal, attaching the current version of the definitive agreement relating
to such Superior Proposal (a "Superior Proposal Notice") (it being understood
that the Superior Proposal Notice shall not constitute a Recommendation Change
for purposes of this Agreement); (C) if requested by Parent, the Company shall
have made the Company Representatives available to discuss with the Parent
Representatives, and to negotiate in good faith with the Parent
Representatives, any proposed modifications to the terms and conditions of
this Agreement during the three (3) Business Day period following delivery by
the Company to Parent of such Superior Proposal Notice; and (D) if Parent
shall have delivered to the Company during such three (3) Business Day period
a written, binding and irrevocable (through the expiration of such three (3)
Business Day period) offer which is set forth in a definitive written
amendment to this Agreement delivered to the Company and executed on behalf of
Parent and Merger Sub, the Company Board shall have determined in good faith,
after considering the terms of such offer by Parent, that the Acquisition
Proposal giving rise to such Superior Proposal Notice continues to constitute
a Superior Proposal. If the Company Board shall have determined that such
Acquisition Proposal no longer constitutes a Superior Proposal or if the terms
of any Acquisition Proposal are modified in any material respect, then, in
each case, any such modified Acquisition Proposal from the party that
submitted such Acquisition Proposal shall require a new Superior Proposal
Notice and a new three (3) Business Day period as set forth above.

  

   
 

 

 

 

  

 

50  

  

 

 

 

   
 

(c) The Company (i) will promptly (and in no event later than within 24 hours)
notify Parent orally and in writing of the receipt by the Company of any
Acquisition Proposal or any inquiry or request for discussion regarding an
Acquisition Proposal including any request for information, the terms and
conditions of such request, Acquisition Proposal or inquiry and the identity
of the Person making such request, Acquisition Proposal or inquiry (including
copies of any document or correspondence evidencing such Acquisition Proposal
or inquiry) and (ii) will keep Parent informed of any material changes
(including any changes to price, merger consideration, financing terms, if
any, and closing conditions) to any such Acquisition Proposal, inquiry or
request. The Company shall not, and shall cause the Company Representatives
not to, enter into any Contract with any Person subsequent to the date of this
Agreement that would restrict the Company's ability to provide such
information relating to the Company to Parent, and the Company is not
currently a party to any Contract that prohibits the Company from providing
the information relating to the Company described in this Section 5.09(c) to
Parent.

  

  

(d) Nothing contained in this Agreement shall prevent the Company Board from
(i) taking, and disclosing to the Company's stockholders, a position
contemplated by Rule 14d-9 or Rule 14e-2 promulgated under the Exchange Act
with regard to any tender offer or exchange offer that is an Acquisition
Proposal or (ii) making any disclosure to the Company's stockholders that the
Company Board determines in good faith, after consultation with its outside
legal counsel, that the failure to make such disclosure would be inconsistent
with its fiduciary duties to the Company's stockholders under applicable Law,
so long as the Company at least one (1) Business Day prior to making such
disclosure notifies Parent (or as soon as possible if notifying Parent at
least one (1) Business Day prior to making such disclosure is impractical)
and, if requested in writing by Parent, such disclosure shall contain a
reaffirmation of the Company Board's recommendation to the stockholders of the
Company to approve and adopt this Agreement; provided, however, if Parent
requests reaffirmation in writing and the Company fails to make such
reaffirmation in such disclosure, then such failure shall be deemed to be a
Recommendation Change; provided further, that none of the Company, the Company
Board or any Company Representative, except as permitted by Section 5.09(b),
shall propose to approve or recommend any Acquisition Proposal or make a
Recommendation Change. For the avoidance of doubt, a "stop, look or listen"
communication by the Company Board to the Company's stockholders pursuant to
Rule 14d-9(f) of the Exchange Act, or any substantially similar communication,
shall not be deemed to be a Recommendation Change.

  

  

(e) The Company shall immediately cease, and cause each Company Representative
to immediately cease, any and all existing activities, discussions or
negotiations with any parties (other than Merger Sub, Parent or any of the
Parent Representatives, as applicable) conducted heretofore with respect to
any Acquisition Proposal, and shall promptly request any such parties in
possession of confidential information about the Company that was furnished by
or on behalf of the Company in connection with such Acquisition Proposal to
return or destroy all such information in the possession of any such party or
its representatives.

  

   
 

 

 

 

  

 

51  

  

 

 

 

   
 

(f) For purposes of this Agreement, "Acquisition Proposal" shall mean any
offer or proposal for a merger, acquisition, recapitalization, consolidation,
tender offer, exchange offer or similar transaction involving, or any proposal
or offer to purchase or acquire in any manner (A) assets representing 20% or
more of the assets of the Company or (B) an equity interest in 20% or more of
the voting securities of the Company, other than the Transactions contemplated
by this Agreement.

  

  

(g) For purposes of this Agreement, "Superior Proposal" shall mean any
Acquisition Proposal by a Person other than Parent, Merger Sub or any of their
respective affiliates (substituting 50% for the 20% thresholds set forth in
the definition of "Acquisition Proposal") that the Company Board has
determined in good faith, after consultation with its outside counsel and the
Financial Advisor or other independent financial advisor of nationally
recognized reputation, and taking into account all financial, regulatory,
legal and other aspects of such Acquisition Proposal, (i) is more favorable
from a financial point of view to the Company's stockholders than the Merger
(including any adjustment to the terms and conditions thereof proposed in
writing by Parent in response to any such Acquisition Proposal) and which such
Acquisition Proposal, if it includes non-cash consideration, would result in
the receipt by the Company's stockholders of consideration economically
superior to the consideration such holders are to receive in the Merger; (ii)
is reasonably capable of being consummated no later than nine (9) months from
the receipt of such Acquisition Proposal; and (iii) for which financing, to
the extent required, is then fully committed.

  

  

5.10 Termination of Registration. Each of the parties hereto agrees to
cooperate with the other party in taking, or causing to be taken, all actions
reasonably necessary to terminate the registration of the Common Shares under
the Exchange Act; provided that such termination shall not be effective until
or after the Effective Time.

  

   
 

 

 

 

  

 

52  

  

 

 

 

   
 

5.11 Employment Matters.

  

  

(a) From and after the Effective Time, the Surviving Corporation shall (and
Parent shall cause the Surviving Corporation to) honor the change in control
agreements set forth on Section 5.11(a) of the Company Disclosure Schedule in
accordance with their terms as in effect immediately prior to the Effective
Time; provided, that nothing in this sentence shall prohibit Parent from
amending or terminating, or from causing the Surviving Corporation to amend or
terminate, any such change in control agreement in accordance with its terms
or if otherwise required by applicable Law (with the consent of the employee
covered by any such change in control agreement if required).

  

  

(b) Until the date which is three (3) months after the Effective Time, Parent
shall or shall cause the Surviving Corporation to provide, to each individual
who is actively employed by the Company immediately prior to the Effective
Time and who remains an employee of the Surviving Corporation during such
period (each, a "Continuing Employee"), (i) at least the same level of base
salary or regular wages and (ii) employee benefits that are no less favorable
in the aggregate, than those provided by the Company to Continuing Employees
generally immediately prior to the Effective Time pursuant to the Benefit
Plans (excluding any change in control and equity benefits). Following the
Effective Time, Parent agrees that the Surviving Corporation shall cause the
Surviving Corporation's employee benefit plans established following the
Effective Time (if any) and any other employee benefit plans covering
Continuing Employees following the Effective Time (collectively, the "Post-
Closing Plans") to recognize the service of each Continuing Employee (to the
extent such service was recognized by the Company) with the Company prior to
the Effective Time for purposes of eligibility to participate and vesting
only; provided, however, that such service need not and shall not be credited
for new Parent equity-based awards or for benefit accrual purposes under any
Post-Closing Plan. In addition, and without limiting the generality of the
foregoing, for the calendar year including the Effective Time: (i) each
Continuing Employee shall be immediately eligible to participate, without any
waiting time, in any and all Post-Closing Plans (other than the Benefit Plans)
to the extent coverage under any such Post-Closing Plan replaces coverage
under a comparable Benefit Plan in which such Continuing Employee participates
immediately before the Effective Time; (ii) the Continuing Employees and his
or her covered dependents shall not be required to satisfy any deductible, co-
payment, out-of-pocket maximum or similar requirements under the Post-Closing
Plans that provide medical, dental, pharmaceutical, vision and/or disability
benefits (collectively, the "Post-Closing Welfare Plans") to the extent of
amounts previously credited for such purposes under comparable Benefit Plans
that provide medical, dental, pharmaceutical, vision and/or disability
benefits (the "Company Welfare Plans"); and (iii) any waiting periods, pre-
existing condition exclusions, and evidence of insurability requirements
contained in such Post-Closing Welfare Plans shall be waived for such
Continuing Employee and his or her covered dependents (except to the extent
any such waiting period, pre-existing condition exclusion, or evidence of
insurability requirement was in effect with respect to such individual and had
not been satisfied under the applicable Company Welfare Plan in which the
individual then participates or participated as of immediately prior to the
Effective Time). Any vacation or paid time off accrued but unused by a
Continuing Employee as of immediately prior to the Effective Time (the
"Current PTO Liability") shall be credited to such Continuing Employee
following the Effective Time.

  

   
 

 

 

 

  

 

53  

  

 

 

 

   
 

(c) Notwithstanding anything to the contrary set forth in this Agreement, no
provision of this Agreement shall be deemed to (i) guarantee employment for
any period of time for, or preclude the ability of Parent or the Surviving
Corporation to terminate, any Continuing Employee for any reason, (ii) be
construed as an amendment of any employee benefit plan or policy of Parent or
the Surviving Corporation or their affiliates, or (iii) create any third-party
beneficiary rights in any employee or former employee (including any
beneficiary or dependent of such employee or former employee) of the Company
in respect of their employment or any other matter.

  

  

5.12 Merger Sub. Parent will take all action necessary (a) to cause Merger Sub
to perform its obligations under this Agreement to consummate the Merger on
the terms and conditions set forth in this Agreement and (b) to ensure that,
prior to the Effective Time, Merger Sub shall not conduct any business or make
any investments other than as specifically contemplated by this Agreement.

  

  

5.13 Stockholder Litigation. The Company shall promptly advise Parent in
writing of any Claim brought by any stockholder of the Company against the
Company and/or its directors (in their capacity as such) relating to this
Agreement or the Transactions. Each of the parties hereto shall give the
others the reasonable opportunity to participate in the defense of any
stockholder Claim against the Company, Parent or Merger Sub, as applicable,
and their respective directors (in their capacity as such) relating to this
Agreement or the Transactions. The Company shall not settle any Claim
currently pending, or commenced after the date of this Agreement, against the
Company or any of its directors (in their capacity as such) by any stockholder
of the Company or holder of any Options, Warrants, Restricted Stock or
Restricted Stock Units relating to this Agreement or the Transactions, in each
case, without the prior written consent of Parent (which consent shall not be
unreasonably withheld, conditioned or delayed).

  

  

5.14 Section 16 Matters. Prior to the Effective Time, the Company shall take
all such steps as may be reasonably necessary and permitted to cause the
Transactions, including any dispositions of Company Shares (including
derivative securities with respect to such Common Shares and including the
deemed disposition and cancellation of the Options in the Merger) by each
individual who is or will be subject to the reporting requirements of Section
16(a) of the Exchange Act with respect to the Company, to be exempt under Rule
16b-3 promulgated under the Exchange Act.

  

  

5.15 State Takeover Statutes. If any "fair price," "moratorium," "control
share acquisition," "business combination" or other similar anti-takeover Laws
in the United States (including Section 203 of the DGCL) is or may become
applicable to the Transactions, the parties shall use commercially reasonable
efforts to take such actions as are reasonably necessary so that the
Transactions may be consummated as promptly as practicable on the terms
contemplated hereby, which efforts shall include the Company Board taking all
actions permitted under Applicable Law to render such statutes inapplicable to
the Transactions.

  

   
 

 

 

 

  

 

54  

  

 

 

 

   
 

5.16 Notification of Certain Matters. The Company shall give prompt notice to
Parent and Merger Sub, and Parent and Merger Sub shall give prompt notice to
the Company of (a) any written notice or other communication received from any
Person alleging that the consent of such Person is required in connection with
the Transactions, (b) any notice from any Governmental Authority in connection
with the Transactions, (c) any actions, suits, Claims, investigations or
proceedings commenced or, to such party's Knowledge, threatened against,
relating to or involving or otherwise affecting such party or any of its
subsidiaries which relate to the Transactions, (d) the discovery of any fact
or circumstance, or the occurrence or non-occurrence of any event, that would
reasonably be expected to cause (i) any representation or warranty made by
such party contained in this Agreement that is qualified as to materiality or
"Company Material Adverse Effect" or "Parent Material Adverse Effect," as
applicable, to be untrue or inaccurate (ii) any representation or warranty
made by such party contained in this Agreement that is not qualified as to
materiality or "Company Material Adverse Effect" or "Parent Material Adverse
Effect," as applicable, to be untrue or inaccurate in any manner that would
cause the condition set forth in Section 6.02(a) or Section 6.03(a), as the
case may be, to not be satisfied or (iii) any other condition to the Merger
set forth in Article 6 to be incapable of being satisfied prior to the
Expiration Date, and (e) any material failure of such party to comply with or
satisfy any covenant or agreement to be complied with or satisfied by it
hereunder; provided, however, that the delivery of any notice pursuant to this
Section 5.16 shall not (i) cure any breach of, or non-compliance with, any
other provision of this Agreement or (ii) limit the remedies available to the
party receiving such notice.

  

  

5.17 Retention Agreements. Parent shall provide certain employees individual
retention agreements prepared by Parent (the "Retention Agreements"); provided
that no Retention Agreement shall require the Company to make any payments to
any employees prior to the Effective Time. The Company shall (i) assist
Parent, as and to the extent reasonably requested by Parent, in the creation
of the Retention Agreements, (ii) provide Parent with such information
regarding its employees as may be reasonably requested by Parent for such
purposes, which information may include employee names, addresses, titles,
compensation and current equity holdings, (iii) provide Parent access to the
Company's employees and (iv) cause a duly authorized officer of the Company to
execute the Retention Agreements on behalf of the Company. In the event any
employees shall enter into Retention Agreements, from the date of entering
into the Retention Agreements until the earlier of the termination of this
Agreement pursuant to Article 7 or the Effective Time, the Company shall not
terminate, amend, withdraw, revoke, modify or waive any provision of any
Retention Agreement without Parent\'s prior written approval

  

   
 

 

 

 

  

 

55  

  

 

 

 

   
 

5.18 Corrective Action Plan. The Company shall in all material respects comply
with and implement the corrective action plans set forth on Section 5.18 of
the Company Disclosure Schedule; provided, however, that this Section 5.18
shall have no effect following the occurrence of a Warning Letter Event, in
which case Parent's sole and exclusive recourse shall be a termination of this
Agreement pursuant to Section 7.03(c)(i) with concurrent payment of the
Reverse Break Up Fee pursuant to Section 8.01(d).

  

  

ARTICLE 6 
 

  

  

CONDITIONS TO CONSUMMATION OF THE MERGER

  

  

6.01 Conditions to the Obligations of Each Party. The respective obligations
of the Company, Parent and Merger Sub to consummate the Merger are subject to
the satisfaction or waiver (where permissible under applicable Law), at or
before the Effective Time, of each of the following conditions:

  

  

(a) Company Stockholder Approval. The Company shall have obtained Stockholder
Approval in accordance with the DGCL, and the Company's certificate of
incorporation and bylaws;

  

  

(b) No Orders and Injunctions. No Governmental Authority in the United States
or in any of the jurisdictions set forth in Section 6.01(b) of the Parent
Disclosure Schedule (the "Identified Jurisdictions"), shall have enacted,
issued, promulgated, enforced or entered any Law or Order that is then in
effect and that has the effect of preventing or prohibiting the consummation
of the Merger or otherwise imposing material limitations on the ability of
Merger Sub and Parent to effectively acquire, hold or operate the business of
the Company or Parent; provided, however, that each of the parties hereto
shall use its commercially reasonable efforts to appeal any such Order or
otherwise have any such Order vacated or removed; and

  

  

(c) Antitrust Approvals. (i) Any waiting period (and any extension thereof)
under the HSR Act shall have expired or terminated and (ii) any waiting period
(and any extension thereof), and any necessary consents, approvals, Permits
of, authorizations from, notifications to and filings with any Governmental
Authorities, under any Antitrust Laws of the Identified Jurisdictions, to the
extent applicable, shall have been made or obtained.

  

  

6.02 Conditions to Obligations of Merger Sub and Parent. The obligations of
each of Merger Sub and Parent to consummate the Merger are subject to the
satisfaction, at or before the Effective Time, of each of the following
additional conditions, unless waived by Parent in writing prior to the
Effective Time:

  

   
 

 

 

 

  

 

56  

  

 

 

 

   
 

(a) Representations and Warranties. The representations and warranties of the
Company contained in this Agreement shall be true and correct in all respects
as of the Closing Date as if made on and as of the Closing Date (except to the
extent such representations and warranties expressly relate to an earlier
date, in which case as of such earlier date), except that any inaccuracies in
such representations and warranties will be disregarded if the circumstances
giving rise to all such inaccuracies (considered collectively) do not
constitute a Company Material Adverse Effect (other than (i) the
representations and warranties set forth in Sections 3.02, 3.03 (except as set
forth in clause (ii) below), 3.04, 3.05, 3.18, 3.19 and 3.20 which shall be
true and correct in all respects and (ii) the representations and warranties
set forth in Section 3.03 which shall be true and correct in all respects,
except for insignificant deviations in numerical amounts set forth in the
second, third and fourth sentence of Section 3.03, in each case, as of the
Closing Date as if made on and as of the Closing Date (except to the extent
such representations and warranties expressly relate to an earlier date, in
which case as if made as of such earlier date)); provided, however, that for
purposes of determining the accuracy of such representations and warranties,
all "Company Material Adverse Effect" qualifications and other materiality
qualifications, and any similar qualifications, contained in such
representations and warranties shall be disregarded;

  

  

(b) Covenants and Agreements. The Company shall have, in all material
respects, performed all obligations and complied with all agreements and
covenants required to be performed by it or complied with by it under this
Agreement at or prior to the Effective Time;

  

  

(c) Company Material Adverse Effect. Since the date of this Agreement, there
shall not have occurred any Company Material Adverse Effect which is then
continuing. For the avoidance of doubt, Parent may not assert that the
condition in this Section 6.02(c) has not been satisfied if the fact,
circumstance, effect, event, change or occurrence giving rise to such Company
Material Adverse Effect was disclosed in the Company Disclosure Schedule;

  

  

(d) Officers' Certificate. At the Closing, the Company shall deliver an
Officers' Certificate, duly executed by the Company's Chief Executive Officer
or Chief Financial Officer on behalf of the Company and dated as of the
Closing Date, stating that the conditions to Closing set forth in Sections
6.02(a), (b) and (c) above have been satisfied; and

  

  

(e) Dissenting Shares. The Dissenting Shares shall not constitute more than
10% of the aggregate number of Common Shares outstanding as of the date of
this Agreement.

  

  

6.03 Conditions to Obligation of the Company. The obligations of the Company
to consummate the Merger are subject to the satisfaction, at or before the
Effective Time, of each of the following additional conditions, unless waived
by the Company in writing prior to the Effective Time:

  

   
 

 

 

 

  

 

57  

  

 

 

 

   
 

(a) Representations and Warranties. The representations and warranties of
Parent and Merger Sub contained in this Agreement shall be true and correct in
all respects as of the Closing Date as if made on and as of the Closing Date
(except to the extent such representations and warranties expressly relate to
an earlier date, in which case as of such earlier date), except that any
inaccuracies in such representations and warranties will be disregarded if the
circumstances giving rise to all such inaccuracies (considered collectively)
do not constitute a Parent Material Adverse Effect (other than the
representations and warranties set forth in Section 4.03 and Section 4.05,
which shall be true and correct in all material respects as of the Closing
Date as if made on and as of the Closing Date); provided, however, that for
purposes of determining the accuracy of such representations and warranties,
all "Parent Material Adverse Effect" qualifications and other materiality
qualifications, and any similar qualifications, contained in such
representations and warranties shall be disregarded;

  

  

(b) Covenants and Agreements. Each of Merger Sub and Parent shall have, in all
material respects, performed all obligations and complied with all agreements
and covenants required to be performed by them or complied with by them under
this Agreement at or prior to the Effective Time; and

  

  

(c) Officers' Certificate. At the Closing, each of Merger Sub and Parent shall
deliver an Officers' Certificate, duly executed by their respective Chief
Financial Officers on behalf of Merger Sub and Parent and dated as of the
Closing Date, stating that the conditions to Closing set forth in Sections
6.03(a) and (b) above have been satisfied.

  

  

ARTICLE 7 
 

  

  

TERMINATION

  

  

7.01 Termination by Mutual Consent. This Agreement may be terminated and the
Merger and other Transactions may be abandoned at any time prior to the
Effective Time, before or after Stockholder Approval, by the mutual written
consent of the Company (acting under the direction of the Company Board) and
Parent.

  

  

7.02 Termination by Parent or the Company. This Agreement may be terminated
and the Merger and other Transactions may be abandoned at any time prior to
the Effective Time, before or after Stockholder Approval, by Parent, on the
one hand, or the Company, acting under the direction of the Company Board, on
the other hand, if:

  

  

(a) any Governmental Authority shall have (i) notified Parent or Company, or
shall have announced, that it has voted to challenge the consummation or
legality of the Merger in a judicial or administrative proceeding; provided,
however, that the right to terminate this Agreement pursuant to this Section
7.02(a) shall not be available to any party that has failed to perform in all
material respects its obligations under Section 5.03, Section 5.07 or the
proviso contained in Section 6.01(b); or (ii) issued or entered any Order that
is in effect and has the effect of preventing or prohibiting the consummation
of the Merger;

  

   
 

 

 

 

  

 

58  

  

 

 

 

   
 

(b) the Merger shall not have been consummated on or before six (6) months
from the date of this Agreement; provided, however, that if on such date, all
of the conditions to the Merger set forth in Article 6, other than (x) any of
the conditions that by their nature are only to be satisfied at the Effective
Time and (y) any of the conditions set forth in or Section 6.01(b) and Section
6.01(c) (but solely, in the case of Section 6.01(b), to the extent the matter
giving rise to the failure of such condition is related to Antitrust Laws),
have been satisfied or waived in writing, then at the election of either the
Company or Parent, such date shall be extended for up to three (3) months
(such date, as may be so extended, the "Expiration Date"); provided, however,
that Parent and the Company shall use commercially reasonable efforts to
consummate any necessary Non-Material Divestiture prior to the Expiration
Date; and provided, further, that the right to terminate this Agreement under
this Section 7.02(b) shall not be available to any party whose failure to
perform any covenant or obligation under this Agreement has been the principal
cause of or principally resulted in the failure of the Merger to have been
consummated on or before the Expiration Date; or

  

  

(c) upon a vote at a duly held Stockholders Meeting (including any adjournment
or postponement thereof) to obtain Stockholder Approval in accordance with
this Agreement, Stockholder Approval shall not have been obtained.

  

  

7.03 Termination by Parent. This Agreement may be terminated and the Merger
and other Transactions may be abandoned at any time prior to the Effective
Time, before or after Stockholder Approval, by Parent, if:

  

  

(a) the Company shall have breached any of its representations, warranties,
covenants or other agreements set forth in this Agreement or any such
representation or warranty shall have become untrue after the date of this
Agreement (in either case, a "Terminating Company Breach") and such
Terminating Company Breach (i) would give rise to the failure of a condition
set forth in Section 6.02(a) or Section 6.02(b) and (ii) has not been cured
within thirty (30) days after written notice thereof is received by the
Company; provided that Parent shall have no right to terminate this Agreement
in connection with a Terminating Company Breach if there is an uncured
Terminating Merger Sub Breach at the time of the Terminating Company Breach or
at the time of the purported termination in connection with a Terminating
Company Breach;

  

  

(b) a Recommendation Change shall have occurred; or

  

  

(c) the Company (i) receives any warning letter, or similar written notice, or
correspondence from the FDA or any other Governmental Authority regulating
medical devices, relating to quality issues, that in the opinion of Parent,
would reasonably be expected to materially impair, or lead to actions that
materially impair, the business of the Company (a "Warning Letter Event");
provided that concurrently with and as a condition to the termination of this
Agreement, Parent pays the Reverse Break Fee, and/or (ii) receives notice of,
or is subject to, any consent decree relating to FDA regulatory or quality
issues.

  

   
 

 

 

 

  

 

59  

  

 

 

 

   
 

7.04 Termination by the Company. This Agreement may be terminated by the
Company, acting under the direction of the Company Board, and the Merger and
other Transactions may be abandoned if:

  

  

(a) at any time prior to the Effective Time, before or after Stockholder
Approval, Merger Sub or Parent shall have breached any of their respective
representations, warranties, covenants or other agreements set forth in this
Agreement or any such representation or warranty shall have become untrue
after the date of this Agreement (in either case, a "Terminating Merger Sub
Breach") and such Terminating Merger Sub Breach (i) would give rise to the
failure of a condition set forth in Section 6.03(a) or Section 6.03(b) and
(ii) is not cured within thirty (30) days after written notice thereof is
received by Merger Sub and Parent; provided that the Company shall have no
right to terminate this Agreement in connection with a Terminating Merger Sub
Breach if there is an uncured Terminating Company Breach at the time of the
Terminating Merger Sub Breach or at the time of the purported termination in
connection with a Terminating Merger Sub Breach; or

  

  

(b) at any time prior to Stockholder Approval, (i) a valid Recommendation
Change shall have occurred after the Company shall have complied with the
procedures set forth in Section 5.09(b) and (ii) concurrently with and as a
condition to the termination of this Agreement pursuant to this Section
7.04(b), the Company enters into a definitive Contract relating to an
Acquisition Proposal not solicited in violation of Section 5.09 that
constitutes a Superior Proposal and pays Parent the Break Up Fee (as defined
in Section 8.01(b)).

  

  

7.05 Effect of Termination. Any proper and valid termination of this Agreement
pursuant to this Article 7 shall be effective immediately upon the delivery of
written notice of the terminating party to the other party or parties hereto,
as applicable. In the event of the termination of this Agreement and
abandonment of the Merger and other Transactions pursuant to this Article 7,
this Agreement shall forthwith become null and void and have no effect,
without any liability on the part of any party or its officers, directors,
stockholders, affiliates and agents, other than the provisions of the third to
last and penultimate sentences of Section 5.04 and the provisions of Sections
5.05, 7.05, and Article 8; provided, however, that nothing herein shall
relieve any party hereto from liability for fraud or any intentional or
willful breach of any of its representations, warranties, covenants or
agreements set forth in this Agreement.

  

  

ARTICLE 8 
 

  

  

MISCELLANEOUS

  

  

8.01 Payment of Fees and Expenses.

  

  

(a) Except as set forth in Section 8.01(b) or as otherwise specified in this
Agreement, each of the parties hereto shall bear its own Expenses incurred by
or on behalf of such party in preparing for, entering into and carrying out
this Agreement and the consummation of the Merger and the Transactions.
"Expenses" as used in this Agreement shall include all out of pocket expenses
(including all fees and expenses of outside counsel, investment bankers,
banks, other financial institutions, accountants, financial printers, experts
and consultants to a party hereto) incurred by a party or on its behalf in
connection with or related to the investigation, due diligence examination,
authorization, preparation, negotiation, execution and performance of this
Agreement and the Transactions and all other matters contemplated by this
Agreement, together with any out of pocket costs and expenses incurred by any
party in enforcing any of its rights set forth in this Agreement, whether
pursuant to litigation or otherwise.

  

   
 

 

 

 

  

 

60  

  

 

 

 

   
 

(b) If this Agreement is terminated (i) by the Company or by Parent pursuant
to Section 7.02(b) or Section 7.02(c) and prior to the Stockholders Meeting,
an Acquisition Proposal (which, for purposes of this Section 8.01(b)(i), shall
have the meaning set forth in the definition of Acquisition Proposal contained
in Section 5.09(f), except that all references to "20% or more" shall be
deemed references to "more than 50%") shall have been made (other than by
Parent, Merger Sub or their respective affiliates) directly to the holders of
Common Shares or shall otherwise have been publicly known and such Acquisition
Proposal had not been withdrawn at the time of the Stockholders Meeting, and
at any time within twelve (12) months after such termination, either the
Company has entered into a definitive Contract relating to any Acquisition
Proposal or a transaction contemplated by an Acquisition Proposal has been
consummated, (ii) by Parent pursuant to Section 7.03(b) or (iii) by the
Company pursuant to Section 7.04(b), then the Company shall (A) in the case of
subparagraph (i), pay to Parent the Break Up Fee (as defined below) within two
(2) Business Days after the event that triggers the obligation to pay the
Break Up Fee, (B) in the case of subparagraph (ii), pay to Parent the Break Up
Fee within two (2) Business Days following such termination of this Agreement
and (C) in the case of subparagraph (iii), pay to Parent the Break Up Fee
concurrently with such termination of this Agreement. "Break Up Fee" means
cash in immediately available funds in an amount equal to $9,000,000.

  

  

(c) If this Agreement is terminated by Parent pursuant to Section 7.03(a)
based on a breach of any covenant or agreement of the Company set forth in
this Agreement (but for the avoidance of doubt, excluding any breach of
representations or warranties), then the Company shall promptly, and in any
event within two (2) Business Days following receipt of documentation
therefor, pay to Parent all of the Expenses of Parent and Merger Sub. If this
Agreement is terminated by Parent pursuant to Section 7.03(a) based on a
breach of any covenant or agreement of the Company set forth in this Agreement
(but for the avoidance of doubt, excluding any breach of representations or
warranties) and prior to such termination, an Acquisition Proposal (which, for
purposes of this Section 8.01(c), shall have the meaning set forth in the
definition of Acquisition Proposal contained in Section 5.09(f), except that
all references to "20% or more" shall be deemed references to "more than 50%")
shall have been made (other than by Parent, Merger Sub or their respective
affiliates) directly to the holders of Common Shares or shall otherwise have
been publicly known and such Acquisition Proposal had not been withdrawn at
the time of such termination, and at any time within twelve (12) months after
such termination, either the Company has entered into a definitive Contract
relating to any Acquisition Proposal or a transaction contemplated by any
Acquisition Proposal has been consummated, then the Company shall pay to
Parent the Break Up Fee within two (2) Business Days after the event that
triggers the obligation to pay the Break Up Fee, provided that the Expenses
payable by the Company to Parent pursuant to this Section 8.01(c) shall be
credited against such Break Up Fee payable by the Company to Parent. If this
Agreement is terminated by the Company pursuant to Section 7.04(a) based on a
breach of any covenant or agreement of Parent or Merger Sub set forth in this
Agreement (but for the avoidance of doubt, excluding any breach of
representations or warranties), then Parent shall promptly, and in any event
within two (2) Business Days following receipt of documentation therefor, pay
to the Company all of the Expenses of the Company.

  

   
 

 

 

 

  

 

61  

  

 

 

 

   
 

(d) If this Agreement is terminated by Parent as a result of a Warning Letter
Event pursuant to Section 7.03(c)(i), then Parent shall concurrently with and
as a condition to such termination, pay to the Company the Reverse Break Up
Fee and, in such case, the Company hereby expressly waives the right to
contest Parent's opinion that the quality issues referenced in the applicable
warning letter, or similar written notice, or correspondence from the FDA or
any other Governmental Authority regulating medical devices that the Company
receives would reasonably be expected to materially impair, or lead to actions
that materially impair, the business of the Company. "Reverse Break Up Fee"
means cash in immediately available funds in an amount equal to $9,000,000.

  

  

(e) The parties agree that the agreements contained in this Section 8.01 are
an integral part of the Transactions and constitute liquidated damages and not
a penalty. Notwithstanding any other provision in this Agreement to the
contrary, (i) if Parent receives the Break Up Fee (and subject to Parent's and
Merger Sub's rights to specifically enforce this Agreement as set forth in
Section 8.11 if Parent challenges the right of the Company to terminate the
Agreement) the parties hereto agree that the payment contemplated by Section
8.01(b) and Section 8.01(c) represents the exclusive remedy of Parent and
Merger Sub in the circumstances described therein and that, except for the
payment expressly set forth in the circumstances described therein, none of
the Company or any of its respective affiliates shall have any liability or
obligation of any kind whatsoever arising out of such termination of this
Agreement, any breach by the Company giving rise to such termination, or the
failure of the Transactions to be consummated as a result of such termination,
whether arising in contract, tort, equity or otherwise and (ii) if the Company
receives the Reverse Break Up Fee, the parties hereto agree that the Reverse
Break Up Fee represents the exclusive remedy of the Company for a valid
termination by Parent pursuant to Section 7.03(c)(i) and that, except for the
payment of the Reverse Break Up Fee, none of Parent or any of its respective
affiliates shall have any liability or obligation of any kind whatsoever
arising out of such termination of this Agreement, any breach by Parent giving
rise to such termination, or the failure of the Transactions to be consummated
as a result of such termination, whether arising in contract, equity, tort or
otherwise.

  

  

(f) All amounts payable by a party under this Section 8.01 shall be paid in
cash and in immediately available funds to such account as the other party may
designate in writing. In the event that (A) the Company shall fail to pay the
Break Up Fee or Parent's and Merger Sub's Expenses required pursuant to this
Section 8.01 when due or (B) Parent shall fail to pay the Company's Expenses
required pursuant to this Section 8.01 when due, then, in each case, such
Break Up Fee or Expenses, as the case may be, shall accrue interest for the
period commencing on the date such Break Up Fee or Expenses, as the case may
be, became past due, at the prime rate, as published in the next edition of
The Wall Street Journal, Eastern Edition, to be published after such delivery,
as the "prime rate" at large U.S. money center banks (which rate shall be
adjusted on the effective date of each change in such rate). If the Company
shall fail to pay the Break Up Fee or Expenses, as the case may be, when due,
the Company shall also pay to the Parent all of the Parent's costs and
expenses (including attorneys' fees) in connection with efforts to collect
such Break Up Fee or Expenses, as the case may be. If the Parent shall fail to
pay the Expenses when due, Parent shall also pay to the Company all of the
Company's costs and expenses (including attorneys' fees) in connection with
efforts to collect such Expenses.

  

   
 

 

 

 

  

 

62  

  

 

 

 

   
 

8.02 No Survival. The representations, warranties and agreements made in this
Agreement and in any certificate delivered pursuant hereto shall not survive
beyond the earlier of the Effective Time or the termination of this Agreement
in accordance with Article 7 hereof. Notwithstanding the foregoing, the
agreements set forth in Article 1, Article 2, Article 8 and Section 5.06 shall
survive the Effective Time and the agreements set forth in Article 8 and those
sections set forth in Section 7.05 shall survive termination.

  

  

8.03 Modification or Amendment. This Agreement may be amended by the parties
hereto at any time before or after Stockholder Approval; provided, however,
that after Stockholder Approval there shall not be made any amendment that by
Law requires the further approval by such stockholders without such further
approval by such stockholders; and provided, further, that the provisions of
Section 5.06 may not be amended or modified after the Closing without the
prior written agreement of each of the Indemnified Parties. Without limiting
the foregoing, this Agreement may not be amended or modified except by an
instrument in writing signed by the parties.

  

  

8.04 Entire Agreement; Assignment. This Agreement (including the Company
Disclosure Schedules and the instruments referred to herein that are executed
pursuant to the terms of this Agreement) and the Confidentiality Agreement
constitute the entire agreement and supersede all prior agreements and
understandings, both written and oral, among the parties with respect to the
subject matter hereof and thereof. EACH PARTY HERETO AGREES THAT, EXCEPT FOR
THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS AGREEMENT, NEITHER PARENT
AND MERGER SUB, ON THE ONE HAND, NOR THE COMPANY, ON THE OTHER HAND, MAKES ANY
REPRESENTATIONS OR WARRANTIES TO THE OTHER, AND EACH PARTY HEREBY DISCLAIMS
ANY OTHER REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED. Neither this
Agreement nor any of the rights, interests or obligations hereunder may be
assigned by any of the parties hereto (whether by operation of law or
otherwise) without the prior written consent of the other party (except that
each of Parent and Merger Sub may assign its rights, interests and obligations
to any of their respective controlled affiliates or direct or indirect wholly-
owned subsidiaries without the consent of the Company, so long as they remain
primarily obligated with respect to any such assigned obligation). Subject to
the preceding sentence, this Agreement will be binding upon, inure to the
benefit of and be enforceable by the parties and their respective successors
and permitted assigns.

  

   
 

 

 

 

  

 

63  

  

 

 

 

   
 

8.05 Severability. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any rule of Law or public
policy, all conditions and provisions of this Agreement shall nevertheless
remain in full force and effect. Upon such determination that any term or
other provision is invalid, illegal or incapable of being enforced, the
parties hereto shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties as closely as possible to the
fullest extent permitted by applicable Law in an acceptable manner to the end
that the Transactions are fulfilled to the extent possible.

  

  

8.06 Notices. Except with respect to delivery of notices contemplated by
Section 5.01, all notices, requests, Claims, demands and other communications
hereunder shall be in writing and shall be deemed to have been duly given (i)
one Business Day after being sent for next business day delivery, fees
prepaid, via a reputable nationwide overnight courier service, or (ii)
immediately upon written or electronic confirmation of delivery via facsimile
or email, to the respective parties as follows:

  

  

If to Parent or Merger Sub:

  

  

C. R. Bard, Inc.

  

730 Central Avenue

  

Murray Hill, New Jersey 07974

  

Attention: Office of General Counsel

  

Facsimile No.: (908) 277-8025 
 

  

  

with copies to:

  

  

Jim Beasley

  

C. R. Bard, Inc.

  

1415 West Third Street

  

Tempe, Arizona 85281

  

Email: jim.beasley@crbard.com

  

Fax: (480) 303-2725

  


 

  

Weil Gotshal and Manges LLP

  

767 Fifth Avenue

  

New York, New York 10153

  

Attention: Michael E. Lubowitz, Esq.

  

Facsimile No.: (212) 310-8007

  

Email: michael.lubowitz@weil.com

   
 

 

 

 

  

 

64  

  

 

 

 

   
 

 

If to the Company:

  

  

SenoRx, Inc.

  

3 Morgan

  

Irvine, California 92618

  

Attention: John T. Buhler

  

Facsimile No.: (949) 362-0300

  

Email: jbuhler@senorx.com 
 

  

  

with a copy to:

  

  

Wilson Sonsini Goodrich and Rosati

  

Professional Corporation

  

650 Page Mill Road

  

Palo Alto, California 94304

  

    

Attention:

  |  

Robert T. Ishii

   
---|--- 
   |  

Martin J. Waters

   
   |  

Elton Satusky

   
 

  

Facsimile No.: (650) 493-6811

  

    

Email:

  |  

rishii@wsgr.com

   
---|--- 
   |  

mwaters@wsgr.com

   
   |  

esatusky@wsgr.com

   
   |   
 

 

  

 

or to such other address as the Person to whom notice is given may have
previously furnished to the other in writing in the manner set forth above;
provided that notice of any change of address shall be effective only upon
receipt thereof.

  

 

  

8.07 Governing Law. This Agreement shall be governed by and construed in
accordance with the Laws of the State of Delaware, regardless of the Laws that
might otherwise govern under applicable principles of conflicts of laws
thereof.

  

  

8.08 Interpretation. Unless otherwise indicated, all references herein to
Articles, Sections, Annexes, Exhibits or Schedules, shall be deemed to refer
to Articles, Sections, Annexes, Exhibits or Schedules of or to this Agreement,
as applicable. The descriptive headings herein are inserted for convenience of
reference only and are not intended to be part of or to affect the meaning or
interpretation of this Agreement. Whenever the words "include," "includes" or
"including" are used in this Agreement, they shall be deemed to be followed by
the words "without limitation." The words "hereof," "herein" and "hereunder"
and words of similar import when used in this Agreement shall refer to this
Agreement as a whole and not to any particular provision of this Agreement.
Whenever the context may require, any pronouns used in this Agreement shall
include the corresponding masculine, feminine or neuter forms, and the
singular form of nouns and pronouns shall include the plural, and vice versa.
The parties hereto agree that the disclosure set forth in any particular
section or subsection of the Company Disclosure Schedules shall be deemed to
be an exception to (or, as applicable, a disclosure for purposes of) (i) the
representations and warranties (or covenants, as applicable) of the Company
that are set forth in the corresponding section or subsection of this
Agreement, and (ii) any other representations and warranties (or covenants, as
applicable) of the Company that are set forth in this Agreement, but in the
case of this clause (ii) only if the relevance of that disclosure as an
exception to (or a disclosure for purposes of) such other representations and
warranties (or covenants, as applicable) is reasonably apparent on the face of
such disclosure.

  

   
 

 

 

 

  

 

65  

  

 

 

 

   
 

8.09 Counterparts. This Agreement may be executed in two or more counterparts,
each of which shall be deemed to be an original, but all of which shall
constitute one and the same agreement, and any one of which may be delivered
by facsimile or other electronic transmission.

  

  

8.10 Certain Definitions. As used in this Agreement:

  

  

(a) "affiliate," as applied to any Person, means any other Person directly or
indirectly controlling, controlled by, or under common control with, that
Person. For the purposes of this definition, "control" (including, with
correlative meanings, the terms "controlling," "controlled by" and "under
common control with"), as applied to any Person, means the possession,
directly or indirectly, of the power to direct or cause the direction of the
management and policies of that Person, whether through the ownership of
voting securities, by contract or otherwise.

  

  

(b) "Antitrust Law" shall mean the Sherman Act, as amended, the Clayton Act,
as amended, the HSR Act, the Federal Trade Commission Act, as amended, and all
other Laws that are designed or intended to prohibit, restrict or regulate
actions having the purpose or effect of monopolization or restraint of trade
or significant impediments to or lessening of competition or the creation or
strengthening of a dominant position through merger or acquisition, in any
case that are applicable to the transactions contemplated by this Agreement.

  

  

(c) "Business Day" shall mean any day other than a Saturday, Sunday or a day
on which the banks in the State of New York are authorized by Law to be
closed.

  

  

(d) "ERISA Affiliate" means any trade or business, whether or not
incorporated, that together with the Company is, or has within the past six
(6) years been, deemed a "single employer" within the meaning of Section 414
of the Code or Section 4001(b) of ERISA.

  

   
 

 

 

 

  

 

66  

  

 

 

 

   
 

(e) "Indebtedness" means, with respect to the Company, (i) indebtedness for
borrowed money or issued in substitution for or exchange of indebtedness for
borrowed money, (ii) obligations evidenced by notes, bonds, debentures,
mortgages or other similar instruments or securities, (iii) obligations under
leases (contingent or otherwise, as obligor, guarantor or otherwise) required
to be accounted for as capitalized leases pursuant to GAAP, (iv) obligations
for amounts drawn under acceptances, letters of credit, contingent
reimbursement liabilities with respect to letters of credit or similar
facilities, (v) any liability for the deferred purchase price of property or
services, contingent or otherwise, as obligor or otherwise, (vi) any liability
which is deemed a long term liability under GAAP, (vii) guarantees and similar
commitments relating to any of the foregoing items, (viii) any accrued and
unpaid interest on, and any prepayment premiums, penalties or similar
contractual charges in respect of, any of the foregoing and (ix) all
obligations of the kind referred to in clauses (i) through (viii) above
secured by (or for which the holder of such obligation has an existing right,
contingent or otherwise, to be secured by) any Lien on property (including
accounts and contract rights) owned by the Company, whether or not such entity
has assumed or become liable for the payment of such obligation.

  

  

(f) "Knowledge" of any Person that is not an individual shall mean, with
respect to any matter in question, the actual knowledge, after due inquiry, of
such Person's officers and, in the case of officers who are managers, after
due inquiry of their direct reports.

  

  

(g) "Person" means any individual, corporation, business, business
organization or division thereof, partnership, limited liability company,
trust, joint venture or any other entity or group (which term shall include a
"group" as such term is defined in Section 13(d)(3) of the Exchange Act).

  

  

(h) "subsidiary" or "subsidiaries" means, with respect to any Person, any
corporation, partnership, limited liability company, joint venture or other
entity of which such Person (either alone or through or together with any
other subsidiary), owns, directly or indirectly, more than 50% of the stock or
other equity or beneficial interests, the holders of which are generally
entitled to vote for the election of the board of directors or other governing
body of such corporation, partnership, limited liability company, joint
venture or other entity.

  

  

(i) "Title IV Plan" means any "employee pension benefit plan," as defined in
Section 3(2) of ERISA, subject to Title IV of ERISA or Section 412 of the Code
(including any "Multiemployer Plan" as defined in Section 3(37) of ERISA or
Section 4001(a)(3) of ERISA).

  

  

(j) "WARN" means the federal Worker Adjustment and Retraining Notification Act
of 1988, 29 U.S.C.  2101 et seq. (1988) and any similar state or local "mass
layoff" or "plant closing" laws.

  

  

  

   
 

 

 

 

  

 

67  

  

 

 

 

  

  

8.11 Specific Performance. 
 

  

(a) Except as described in Section 8.11(b), the parties hereto recognize and
agree that if for any reason any of the provisions of this Agreement are not
performed in accordance with their specific terms or are otherwise breached,
immediate and irreparable harm or injury would be caused for which money
damages would not be an adequate remedy. Accordingly, the parties hereto agree
that, except as described in Section 8.11(b), in addition to other remedies
available to them, the parties shall be entitled to seek specific performance
of the terms hereof. In the event that any action shall be brought in equity
to enforce the provisions of this Agreement no party shall allege, and each
party hereby waives the defense, that there is an adequate remedy at law.
Except as otherwise provided herein, any and all remedies herein expressly
conferred upon a party will be deemed cumulative with and not exclusive of any
other remedy conferred hereby, or by law or equity upon such party, and the
exercise by a party of any one remedy will not preclude the exercise of any
other remedy.

  

  

(b) If this Agreement is validly terminated by Parent as a result of a Warning
Letter Event pursuant to Section 7.03(c)(i), the parties hereto agree that the
Company shall not be entitled to seek specific performance of this Agreement.

  

  

8.12 Extension; Waiver. At any time prior to the Effective Time, a party may
(a) extend the time for the performance of any of the obligations or other
acts of the other party, (b) waive any inaccuracies in the representations and
warranties of the other party contained in this Agreement or in any document
delivered pursuant to this Agreement or (c) subject to the proviso in Section
8.03, waive compliance by the other party with any of the agreements or
conditions contained in this Agreement; provided, however, in each case, any
extension or waiver pursuant to this Section 8.12 shall not be deemed, or
operate as, a continuing extension or waiver. Any agreement on the part of a
party to any such extension or waiver shall be valid only if set forth in an
instrument in writing signed on behalf of such party. The failure of any party
to this Agreement to assert any of its rights under this Agreement or
otherwise shall not constitute a waiver of such rights.

  

  

8.13 Third Party Beneficiaries. This Agreement does not confer upon any Person
other than the parties hereto any rights or remedies, except for the
provisions of Section 5.06.

  

   
 

 

 

 

  

 

68  

  

 

 

 

   
 

  

8.14 Submission to Jurisdiction. Each of the parties hereto irrevocably and
unconditionally submits, for itself and its property, to the exclusive
jurisdiction of the Court of Chancery of the State of Delaware, or, in the
event (but only in the event) that such court does not have subject matter
jurisdiction over any action or proceeding arising out of or relating to this
Agreement, in the federal courts of the United States located in the State of
Delaware ("Delaware Courts"), in any action or proceeding arising out of or
relating to this Agreement. Each of the parties hereto agrees that, subject to
rights with respect to post trial motions and rights of appeal or other
avenues of review, a final judgment in any such action or proceeding shall be
conclusive and may be enforced in other jurisdictions by suit on the judgment
or in any other manner provided by Law. Each of the parties hereto irrevocably
and unconditionally waives, to the fullest extent it may legally and
effectively do so, any objection that it may now or hereafter have to the
laying of venue of any suit, action or proceeding arising out of or relating
to this Agreement in the Delaware Courts. Each of the parties hereto
irrevocably and unconditionally waives, to the fullest extent it may legally
and effectively do so, the defense of an inconvenient forum to the maintenance
of such action or proceeding in any such court.

  

  

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

  

  

  

  

  

  

  

  

   
 

 

 

 

  

 

69  

  

 

 

 

   
 

IN WITNESS WHEREOF, each of the parties has caused this Agreement and Plan of
Merger to be executed on its behalf by its respective officer thereunto duly
authorized, all as of the day and year first above written.

  

  


 

  

 

     |  

SENORX, INC.

  |   
---|---|--- 
   |  |  |   
  

  |  

By:

  | /s/ John T. Buhler |   
   |  | Name: John T. Buhler |   
   |  | Title: President and Chief Executive Officer  |   
   |  |  |   
 

 

  


 

  

 

     |  

C. R. BARD, INC.

  |   
---|---|--- 
   |  |  |   
  

  |  

By:

  | /s/ Todd C. Schermerhorn |   
   |  | Name: Todd C. Schermerhorn |   
   |  | Title: Senior Vice President and Chief Financial Officer |   
   |  |  |   
 

 

  


 

  

 

     |  

RAPTOR ACQUISITION CORP.

  |   
---|---|--- 
   |  |  |   
  

  |  

By:

  | /s/ Todd C. Schermerhorn |   
   |  | Name: Todd C. Schermerhorn  |   
   |  | Title: Vice President |   
   |  |  |   
 

 

  


 

  

  

Signature Page to Agreement and Plan of Merger

   
 

 

 

 

  

   

  

 

 

 

   
 

Schedule I

  

Parties to the Support Agreement

  


 

  

De Novo (Q) Ventures I, L.P.

  

De Novo Ventures I, L.P.

  


 

  

John T. Buhler

  

Paul Lubock

  

Kevin J. Cousins

  

William F. Gearhart

   
 

 

 

 

  

   

  

 

 

 

   
        '

